1
|
Huang Y, Meng L, Zhou R, Luo F. [Clinical characteristics and therapeutic effectiveness of post craniotomy cervicogenic headache]. Zhonghua Yi Xue Za Zhi 2023; 103:2971-2974. [PMID: 37752058 DOI: 10.3760/cma.j.cn112137-20230203-00162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/28/2023]
Abstract
From January 2019 to December 2021, the clinical data of 151 patients with post craniotomy cervicogenic headache from Beijing Tiantan Hospital affiliated to Capital Medical University were retrospectively collected. The characteristics of cervicogenic headache were summarized, the numerical rating score (NRS) of patients before and after treatment of compound opioids and/or cervical nerve block was compared, and the occurrence of related adverse reactions and complications was counted. The onset of cervicogenic headache in 151 patients was on the (5.5±2.0) d after craniotomy, of which 131 (86.8%) had unilateral pain, pain in 127 (84.1%) could be induced by cervical activity, and 118 (78.1%) had limited neck movement. Of the 124 patients treated with compound capsule of oxycodone and acetaminophen, 85 (68.5%) patients had an NRS of (8.01±0.82) before treatment and 2.0 (1.0, 3.0) after treatment (P<0.001). Thirty-nine patients who did not respond to medical therapy received cervical nerve block, and the NRS scores before and after receiving the nerve block were (7.49±1.12) and 2.0 (1.0, 2.5), respectively, with a statistically significant difference (P<0.001). Twenty-seven patients who received cervical nerve block without medical treatment, and the NRS before and after treatment was (9.0±0.9) and 1.0 (1.0, 3.0), respectively, with a statistically significant difference (P<0.001). Among the 124 patients receiving medication, 14 (11.3%) developed mild dizziness and nausea, which were resolved after stopping the drug, and no other drug-related adverse reactions were found. None of the patients who received nerve blocks saw complications associated with nerve block procedures. Compound capsule of oxycodone and acetaminophen are effective for most of patients with post craniotomy cervicogenic headache. Cervical nerve block is effective and safe for patients with or without drug resistance.
Collapse
Affiliation(s)
- Y Huang
- Department of Operating Management Office, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
| | - L Meng
- Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
| | - R Zhou
- Department of Operating Management Office, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
| | - F Luo
- Department of Pain Management, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
| |
Collapse
|
2
|
Luo F, Xin L, Wang J, Qi S, Wang S, Li YX. Optimizing the Combination of Cytotoxic Drugs Along with Radiotherapy as Effective Treatment for Extranodal NK/T-Cell Lymphoma. Int J Radiat Oncol Biol Phys 2023; 117:e476-e477. [PMID: 37785509 DOI: 10.1016/j.ijrobp.2023.06.1691] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The optimal combination of cytotoxic drugs along with radiotherapy (RT) is unknown. We undertook multidrug screening process to identify the most efficacious cytotoxic drugs, and appraise the efficacy of various drug combinations. MATERIALS/METHODS We reviewed 3105 patients who received 40 chemotherapy regimens with different combinations of nine drug classes and/or RT. Least absolute shrinkage and selection operator (LASSO) and multivariable Cox regression analyses were used to screen efficacious single drugs and identify optimal combinations for overall survival (OS). Inverse probability of treatment weighting (IPTW) and multivariable analyses were used to compare survival between treatment regimens. RESULTS Screening and validation revealed RT, asparaginase (ASP), and gemcitabine (GEM) to be the most efficacious single modality/drugs. RT remained an important component of first-line treatment, whereas ASP was a fundamental drug of non-anthracycline (ANT)-based regimens. Addition of RT to non-ANT-based or ASP/GEM-based regimens, or addition of an ASP-drug into ANT-based or GEM/PLA-based regimens, improved 5-year OS significantly. Use of ASP/GEM-based regimens led to significantly higher 5-year OS (79.9%) compared with ASP/ANT-based (69.2%, P = 0.001), ASP/MTX-based (63.5%, P = 0.011), or ASP/NOS-based (63.2%, P<0.001) regimens. The survival benefit of ASP/GEM-based regimens over other ASP-based regimens was substantial across risk-stratified and advanced-stage subgroups. The survival benefits of a combination of RT, ASP, and GEM were consistent after adjustment for confounding factors by IPTW. CONCLUSION These results suggest that combining ASP/GEM with RT for ENKTCL is an efficacious and feasible therapeutic option, and provides a rationale and strategy for developing combination therapies.
Collapse
Affiliation(s)
- F Luo
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - L Xin
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y X Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
3
|
Zhao Z, Wu Y, Liang X, Liu J, Luo Y, Zhang Y, Li T, Liu C, Luo X, Chen J, Wang Y, Wang S, Wu T, Zhang S, Yang D, Li W, Yan J, Ke Z, Luo F. Sonodynamic Therapy of NRP2 Monoclonal Antibody-Guided MOFs@COF Targeted Disruption of Mitochondrial and Endoplasmic Reticulum Homeostasis to Induce Autophagy-Dependent Ferroptosis. Adv Sci (Weinh) 2023; 10:e2303872. [PMID: 37661565 PMCID: PMC10602529 DOI: 10.1002/advs.202303872] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 08/24/2023] [Indexed: 09/05/2023]
Abstract
The lethality and chemotherapy resistance of pancreatic cancer necessitates the urgent development of innovative strategies to improve patient outcomes. To address this issue, we designed a novel drug delivery system named GDMCN2,which uses iron-based metal organic framework (Fe-MOF) nanocages encased in a covalent organic framework (COF) and modified with the pancreatic cancer-specific antibody, NRP2. After being targeted into tumor cells, GDMCN2 gradually release the sonosensitizer sinoporphyrin sodium (DVDMS) and chemotherapeutic gemcitabine (GEM) and simultaneously generated reactive oxygen species (ROS) under ultrasound (US) irradiation. This system can overcome gemcitabine resistance in pancreatic cancer and reduce its toxicity to non-targeted cells and tissues. In a mechanistic cascade, the release of ROS activates the mitochondrial transition pore (MPTP), leading to the release of Ca2+ and induction of endoplasmic reticulum (ER) stress. Therefore, microtubule-associated protein 1A/1B-light chain 3 (LC3) is activated, promoting lysosomal autophagy. This process also induces autophagy-dependent ferroptosis, aided by the upregulation of Nuclear Receptor Coactivator 4 (NCOA4). This mechanism increases the sensitivity of pancreatic cancer cells to chemotherapeutic drugs and increases mitochondrial and DNA damage. The findings demonstrate the potential of GDMCN2 nanocages as a new avenue for the development of cancer therapeutics.
Collapse
Affiliation(s)
- Zhiyu Zhao
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Yanjie Wu
- School of Science and EngineeringShenzhen Key Laboratory of Innovative Drug SynthesisThe Chinese University of Hong KongShenzhen518172P.R. China
| | - Xiaochen Liang
- Environmental ToxicologyUniversity of CaliforniaRiversideCalifornia92507USA
| | - Jiajing Liu
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Yi Luo
- School of Basic MedicineSchool of Clinical MedicineFujian Medical UniversityFuzhou350122P.R. China
| | - Yijia Zhang
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Tingting Li
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Cong Liu
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Xian Luo
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Jialin Chen
- School of Basic MedicineSchool of Clinical MedicineFujian Medical UniversityFuzhou350122P.R. China
| | - Yunjie Wang
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Shengyu Wang
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Ting Wu
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Shaoliang Zhang
- Shanghai Guangsheng Biopharmaceutical Co., LtdShanghai200120P.R. China
| | - Dong Yang
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Wengang Li
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Jianghua Yan
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| | - Zhihai Ke
- School of Science and EngineeringShenzhen Key Laboratory of Innovative Drug SynthesisThe Chinese University of Hong KongShenzhen518172P.R. China
| | - Fanghong Luo
- Cancer Research CenterSchool of MedicineXiamen UniversityXiamen361000P.R. China
| |
Collapse
|
4
|
Wang J, Liu X, Luo F, Wang X, Liu Y, Hu C, Qi S, Li Y. Association of Overall Survival Benefit Profile of Radiotherapy with Progression-Free Survival after Chemotherapy for Diffuse Large B-Cell Lymphoma. Int J Radiat Oncol Biol Phys 2023; 117:S63-S64. [PMID: 37784543 DOI: 10.1016/j.ijrobp.2023.06.364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Benefit of radiotherapy (RT) after chemotherapy (CT) of diffuse large B-cell lymphoma (DLBCL) remains controversial. It is unknown whether improved progression-free survival (PFS) by RT translate into an overall survival (OS) benefit. To address this question, our research comprehensively evaluated the risk-benefit assessment of RT in DLBCL through an in-depth examination of previously reported data from randomized controlled trials (RCTs) and retrospective comparative studies. MATERIALS/METHODS After screening and quality control, this study included 7 randomized controlled trials and 52 retrospective studies of combined-modality therapy (CMT) versus CT alone. The correlation between PFS and OS was evaluated using the Pearson linear correlation coefficient at trial- and study arm-level. A risk-benefit assessment to describe the OS benefit of RT was performed in meta-analyses of pooled HROS with PFS patterns. RESULTS In RCTs, strong correlations were found between HRPFS and HROS at trial-level (r = 0.876), and PFS and OS at treatment arm-level, regardless of treatments (r = 0.945-0.964 for all, CMT or CT). In retrospective studies, similar correlations between HRPFS and HROS (r = 0.639-0.650), and PFS and OS rates (r = 0.882-0.910) were observed, independent of treatments or rituximab. Adding RT into rituximab-based CT increased the average PFS rate from 63.6 ± 18.9% to 81.5 ± 10.6% (P<0.001), with differential OS benefits of RT between studies. Patients can be stratified into four PFS patterns (>80%, >60-80%, >40-60%, and ≤40%); absolute gain in OS from RT ranged from ≤5% at PFS >80% to ∼21% at PFS ≤40%, with pooled-HROS from 0.70 (95% CI, 0.51-0.97) to 0.48 (95% CI, 0.36-0.63) after rituximab-based CT. Linear analysis revealed an OS advantage of CMT over CT alone in a PFS-dependent manner. CONCLUSION We demonstrate a varied OS benefit profile of RT upon different PFS patterns, and provide valuable evidence for making treatment decisions and designing clinical trials. Future strategies to select the use of RT will need careful tailoring in clinical practice or within RCT to optimize outcome.
Collapse
Affiliation(s)
- J Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China; Department of Oncology, Central hospital affiliated to Shandong First Medical University, Jinan, Shandong, China
| | - X Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - F Luo
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - Y Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China
| | - C Hu
- Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - S Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
5
|
Wang X, Qi S, Liu X, Wu Y, Wang J, Luo F, Liu Y, Li Y. Radiotherapy Effect on Long-Term Net Survival Benefit for Early-Stage Diffuse Large B-Cell Lymphoma in the Rituximab Era. Int J Radiat Oncol Biol Phys 2023; 117:e492. [PMID: 37785553 DOI: 10.1016/j.ijrobp.2023.06.1724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) It is controversial whether to add consolidative radiotherapy (RT) after chemoimmunotherapy in the first-line treatment for diffuse large B-cell lymphoma (DLBCL). This study aimed to investigate the long-term net survival benefit of RT for early-stage DLBCL in the rituximab era. MATERIALS/METHODS The data of 10,841 adult patients with early-stage DLBCL from the Surveillance, Epidemiology, and End Results (SEER) database between 2002 and 2015 were extracted and analyzed. The patients had received combined modality treatment (CMT, chemotherapy plus RT) or chemotherapy alone. Linear regression analysis was performed for RT utilization by year of diagnosis. Competing risk analysis was used to evaluate the cumulative incidence of mortality according to the cause of death. Inverse probability of treatment weighting (IPTW) was used to balance the distribution of covariates between treatment arms. Relative survival (RS), standardized mortality ratio (SMR), and transformed Cox regression were performed to estimate the net survival benefit of RT by controlling for background mortality. RESULTS Linear regression revealed that the slope of the best-fit line for RT utilization over time was negative between 2002 and 2015 (m = -0.006, P = 0.003). A total of 4,648 deaths were recorded among 10,841 patients; 55.6% were lymphoma-related death (LRD), and 44.4% were attributed to other causes. Patients initially treated with CMT had a lower cumulative incidence of LRD than chemotherapy alone (HR 0.63, 95% CI: 0.57-0.69; P < 0.001). The 10-year overall survival (OS) rate of 66.1%, RS rate of 85.0%, and SMR of 1.71 achieved with CMT were significantly better than chemotherapy alone (OS, 53.0%; RS, 69.8%; SMR, 2.62; P < 0.001). By IPTW and multivariable analysis, the addition of RT remained associated with better OS (HR 0.67, 95% CI: 0.62-0.71; P < 0.001) and RS (HR 0.69, 95% CI: 0.65-0.74; P < 0.001). CONCLUSION RT was associated with better long-term net survival in patients with early-stage DLBCL in the rituximab era.
Collapse
Affiliation(s)
- X Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - S Qi
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - X Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Wu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - J Wang
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - F Luo
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Liu
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Li
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| |
Collapse
|
6
|
Huang K, Lin Y, Qiu G, Wang S, Feng L, Zheng Z, Gao Y, Fan X, Zheng W, Zhuang J, Luo F, Feng S. Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy. Aging (Albany NY) 2023; 15:8113-8136. [PMID: 37595258 PMCID: PMC10497016 DOI: 10.18632/aging.204958] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2023] [Accepted: 07/19/2023] [Indexed: 08/20/2023]
Abstract
OBJECTIVE Pyroptosis is a form of programmed cell death that is essential for immunity. Herein, this study was conducted to uncover the implication of pyroptosis in immunomodulation and tumor microenvironment (TME) in gastric cancer. METHODS Prognostic pyroptosis-related genes were extracted to identify different pyroptosis phenotypes and pyroptosis genomic phenotypes via unsupervised clustering analysis in the gastric cancer meta-cohort cohort (GSE15459, GSE62254, GSE84437, GSE26253 and TCGA-STAD). The activation of hallmark gene sets was quantified by GSVA and immune cell infiltration was estimated via ssGSEA and CIBERSORT. Through PCA algorithm, pyroptosis score was conducted. The predictors of immune response (TMB and IPS) and genetic mutations were evaluated. The efficacy of pyroptosis score in predicting immune response was verified in two anti-PD-1 therapy cohorts. RESULTS Three different pyroptosis phenotypes with different prognosis, biological pathways and tumor immune microenvironment were established among 1275 gastric cancer patients, corresponding to three immune phenotypes: immune-inflamed, immune-desert, and immune-excluded. According to the pyroptosis score, patients were separated into high and low pyroptosis score groups. Low pyroptosis score indicated favorable survival outcomes, enhanced immune responses, and increased mutation frequency. Moreover, low pyroptosis score patients displayed more clinical benefits from anti-PD-1 and prolonged survival time. CONCLUSION Our findings uncovered a nonnegligible role of pyroptosis in immunomodulation and TME multiformity and complicacy in gastric cancer. Quantifying the pyroptosis score in individual tumors may tailor more effective immunotherapeutic strategies.
Collapse
Affiliation(s)
- Kaida Huang
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Yubiao Lin
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Guoqin Qiu
- Chenggong Hospital Affiliated to Xiamen University, Xiamen 361003, Fujian, China
| | - Shengyu Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Lihua Feng
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Zhigao Zheng
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Yingqin Gao
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Xin Fan
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Wenhui Zheng
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Jianmin Zhuang
- Department of General Surgery, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
| | - Fanghong Luo
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Shuitu Feng
- Department of Oncology, Xiamen Haicang Hospital, Xiamen 361026, Fujian, China
- Fudan University Shanghai Cancer Center Xiamen Hospital, Xiamen 361000, Fujian, China
| |
Collapse
|
7
|
Li M, Liu J, Luo X, Zhao Z, Wang S, Liu Z, Li T, Yang D, Li Y, Wang P, Luo F, Yan J. Monoclonal Antibody-Guided Tumor-Targeted Hollow Virus-Like Cerium Oxide with Oxygen Self-Supply for Intensifying Photodynamic Therapy. Adv Healthc Mater 2023; 12:e2202418. [PMID: 36459700 DOI: 10.1002/adhm.202202418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 11/17/2022] [Indexed: 12/05/2022]
Abstract
The hypoxic character of tumors and the poor targeting ability of photosensitizers often limit the efficacy of photodynamic therapy (PDT). In recent years, the discovery of metal nanoenzymes and nanocarriers has improved PDT. Thereby, to improve the effective utilization of photosensitizers and oxygen (O2 ) in tumors, herein, a nanosystem (LS-HB@HvCeO2 -NRP1 mAb, LHCN1) is reported, in which a hollow virus-like cerium oxide (HvCeO2 ) is surface-decorated with tumor-targeting neuropilin-1 monoclonal antibody (NRP1 mAb), and loaded with a photosensitizer (chlorin e6-C-15-ethyl ester, LS-HB). In vitro and in vivo experiments demonstrate that LHCN1 can efficiently accumulate within the tumor sites via the targeting guidance of NRP1 mAb and is then rapidly endocytosed into cells. Furthermore, HvCeO2 with catalase-mimetic activity can decompose the endogenous hydrogen peroxide (H2 O2 ) to promote O2 via the valence transformation between Ce4+ and Ce3+ , relieving tumor hypoxia and improving the PDT efficacy. Upon near-infrared laser irradiation, LS-HB produces large amounts of cytotoxic reactive oxygen species. Moreover, LHCN1 is used in fluorescence/photoacoustic multimodal imaging for in vivo drug localization, and its use in PDT evidently helps inhibit tumor growth with no apparent toxicity to normal tissues. Thus, LHCN1 may provide a promising strategy for precise tumor-specific diagnosis and treatment.
Collapse
Affiliation(s)
- Mengqi Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Jiajing Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Xian Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Zhiyu Zhao
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Zongjunlin Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Tingting Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Dong Yang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Yang Li
- Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Science, Fuzhou, 350007, P. R. China
| | - Peiyuan Wang
- Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Science, Fuzhou, 350007, P. R. China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 36100, P. R. China
| |
Collapse
|
8
|
Fu C, Shao T, Hou M, Qu J, Li P, Yang Z, Shan K, Wu M, Li W, Wang X, Zhang J, Luo F, Zhou L, Sun J, Zhao F. Preoperative prediction of tumor deposits in rectal cancer with clinical-magnetic resonance deep learning-based radiomic models. Front Oncol 2023; 13:1078863. [PMID: 36890815 PMCID: PMC9986582 DOI: 10.3389/fonc.2023.1078863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Accepted: 02/06/2023] [Indexed: 02/22/2023] Open
Abstract
Background This study aimed to establish an effective model for preoperative prediction of tumor deposits (TDs) in patients with rectal cancer (RC). Methods In 500 patients, radiomic features were extracted from magnetic resonance imaging (MRI) using modalities such as high-resolution T2-weighted (HRT2) imaging and diffusion-weighted imaging (DWI). Machine learning (ML)-based and deep learning (DL)-based radiomic models were developed and integrated with clinical characteristics for TD prediction. The performance of the models was assessed using the area under the curve (AUC) over five-fold cross-validation. Results A total of 564 radiomic features that quantified the intensity, shape, orientation, and texture of the tumor were extracted for each patient. The HRT2-ML, DWI-ML, Merged-ML, HRT2-DL, DWI-DL, and Merged-DL models demonstrated AUCs of 0.62 ± 0.02, 0.64 ± 0.08, 0.69 ± 0.04, 0.57 ± 0.06, 0.68 ± 0.03, and 0.59 ± 0.04, respectively. The clinical-ML, clinical-HRT2-ML, clinical-DWI-ML, clinical-Merged-ML, clinical-DL, clinical-HRT2-DL, clinical-DWI-DL, and clinical-Merged-DL models demonstrated AUCs of 0.81 ± 0.06, 0.79 ± 0.02, 0.81 ± 0.02, 0.83 ± 0.01, 0.81 ± 0.04, 0.83 ± 0.04, 0.90 ± 0.04, and 0.83 ± 0.05, respectively. The clinical-DWI-DL model achieved the best predictive performance (accuracy 0.84 ± 0.05, sensitivity 0.94 ± 0. 13, specificity 0.79 ± 0.04). Conclusions A comprehensive model combining MRI radiomic features and clinical characteristics achieved promising performance in TD prediction for RC patients. This approach has the potential to assist clinicians in preoperative stage evaluation and personalized treatment of RC patients.
Collapse
Affiliation(s)
- Chunlong Fu
- Department of Radiology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
| | - Tingting Shao
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Min Hou
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jiali Qu
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Ping Li
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.,Department of Radiology, Jiaxing Hospital of Traditional Chinese Medicine, Jiaxing, China
| | - Zebin Yang
- Department of Radiology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
| | - Kangfei Shan
- Department of Radiology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
| | - Meikang Wu
- Department of Radiology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
| | - Weida Li
- Department of Radiology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
| | - Xuan Wang
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jingfeng Zhang
- Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo, China
| | - Fanghong Luo
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Long Zhou
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China
| | - Jihong Sun
- Department of Radiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.,Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo, China.,Cancer Center, Zhejiang University, Hangzhou, China
| | - Fenhua Zhao
- Department of Radiology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, China
| |
Collapse
|
9
|
Xie F, Liu Z, Wang P, Cai M, Li Y, Yan J, Lin Q, Luo F. Self-Delivering Nanodrugs Developed via Small-Molecule-Directed Assembly and Macrophage Cloaking for Sonodynamic-Augmented Immunotherapy. Adv Healthc Mater 2022; 11:e2202115. [PMID: 36127303 DOI: 10.1002/adhm.202202115] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
10
|
Liu C, Shi L, Li W, Huang Z, Wang S, Xu P, Li T, Li Z, Luo F, Li W, Yan J, Wu T. AKR1B10 accelerates the production of proinflammatory cytokines via the NF-κB signaling pathway in colon cancer. J Mol Histol 2022; 53:781-791. [PMID: 35920984 DOI: 10.1007/s10735-022-10093-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Accepted: 07/20/2022] [Indexed: 12/28/2022]
Abstract
Aldo-keto reductase family one, member B10 (AKR1B10) has been reported to be involved in the tumorigenesis of various cancers. It has been reported that colorectal cancer is closely associated with chronic inflammation, but the underlying molecular mechanisms are still elusive. In our study, we evaluated the relationship between AKR1B10 expression and clinicopathological characteristics of colon cancer and showed that AKR1B10 expression was significantly correlated with the T stage and clinical stage of colon cancer. Knockdown of AKR1B10 significantly decreased the expression of the inflammatory cytokines IL1α and IL6 induced by lipopolysaccharide by inhibiting the NF-κB signaling pathway. Furthermore, AKR1B10 depends on its reductase activity to affect the NF-κB signaling pathway and subsequently affect the production of inflammatory cytokines. In addition, knockdown of AKR1B10 effectively reduced cell proliferation and clonogenic growth, indicating the biological role of AKR1B10 in colon cancer. Together, our findings provide important insights into a previously unrecognized role of AKR1B10 in colon cancer.
Collapse
Affiliation(s)
- Cong Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Lei Shi
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Wanyun Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Zilan Huang
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Peilan Xu
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Tingting Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Zhenyu Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China.
| | - Wengang Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China.
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China.
| | - Ting Wu
- Cancer Research Center, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361102, Fujian, China.
- Department of Basic Medicine, School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, 361000, China.
| |
Collapse
|
11
|
Xie F, Liu Z, Wang P, Cai M, Li Y, Yan J, Lin Q, Luo F. Self-Delivering Nanodrugs Developed via Small-Molecule-Directed Assembly and Macrophage Cloaking for Sonodynamic-Augmented Immunotherapy. Adv Healthc Mater 2022; 11:e2102770. [PMID: 35575205 DOI: 10.1002/adhm.202102770] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Revised: 05/09/2022] [Indexed: 01/24/2023]
Abstract
The self-delivery of sonosensitizers and immunomodulators to tumor areas, which is highly recommended for enhancing sonodynamic immunotherapy, remains a challenge. Herein, a self-delivering nanodrug (HB-NLG8189, drug loading: ≈100 wt%) is developed by the small-molecule self-assembly of "HB" (a new clinical photosensitizer) and NLG8189 (indoleamine-(2,3)-dioxygenase (IDO) pathway inhibitor) for sonodynamic-augmented immunotherapy; this preparation method ensures the absence of excipient-related toxicity and immunogenicity. To evade immune recognition and prolong the circulation time, the HB-NLG8189 nanodrugs are camouflaged using macrophage cell membranes (MPCMs). The constructed HB-NLG8189@MPCM nanodrugs show an ability to preferentially accumulate within tumors. Upon ultrasound triggering, the HB-NLG8189@MPCM is able to generate reactive oxygen species efficiently for robust sonodynamic therapy; it induces immunogenic cell death, initiates an antitumor immune response to activate tumor-specific effector T cells, and promotes the secretion of inflammatory cytokines. The concomitant delivery of NLG8189 reverses the immunosuppressive tumor microenvironment by restraining IDO-1 activation and the intratumoral infiltration of regulatory T cells. Sonodynamic-augmented immunotherapy with HB-NLG8189@MPCM significantly inhibits the growth of both primary and distant tumors with little systemic toxicity. The biomimetic self-delivery nanodrug provides a promising paradigm for improving sonodynamic immunotherapy.
Collapse
Affiliation(s)
- Fang Xie
- Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, P. R. China
| | - Zongjunlin Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361000, P. R. China
| | - Peiyuan Wang
- Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, 350007, P. R. China
| | - Meimei Cai
- Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, P. R. China
| | - Yang Li
- Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou, 350007, P. R. China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361000, P. R. China
| | - Qin Lin
- Department of Radiation Oncology, Xiamen Cancer Center, Xiamen Key Laboratory of Radiation Oncology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361000, P. R. China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, 361000, P. R. China
| |
Collapse
|
12
|
Zhou S, Luo F, Gu M, Lu X, Xu Y, Wu R, Xiong J, Ran X. Biopsy-tract haemocoagulase injection reduces major complications after CT-guided percutaneous transthoracic lung biopsy. Clin Radiol 2022; 77:e673-e679. [PMID: 35788268 DOI: 10.1016/j.crad.2022.05.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2022] [Revised: 05/11/2022] [Accepted: 05/20/2022] [Indexed: 11/03/2022]
Abstract
AIM To determine whether the injection of haemocoagulase into the biopsy tract can reduce pneumothorax and pulmonary haemorrhage after computed tomography (CT)-guided percutaneous transthoracic lung biopsy (PTLB). MATERIALS AND METHODS A retrospective study was performed involving patients with undiagnosed pulmonary lesions scheduled for PTLB between January 2020 and March 2021. Patients were assigned to the haemocoagulase group or the non-haemocoagulase group. After CT-guided biopsies were performed with a 17 G coaxial system, patients in the haemocoagulase group received a haemocoagulase injection (0.2-0.5 units) in the biopsy tract as the sheath was withdrawn. Postoperative image studies were performed to evaluate complications, including pneumothorax and pulmonary haemorrhage. Factors, including the patient's position, lesion location, and pathological results, were evaluated to determine their associations with the complications. RESULTS A total of 100 patients were included, with 44 men and a mean age of 53 years old. The overall incidences of pneumothorax and pulmonary haemorrhage were 15% and 13%, respectively. The incidences of pneumothorax and pulmonary haemorrhage were statistically significantly lower in the haemocoagulase group (8% and 6%, respectively) than in the non-haemocoagulase group (22% and 20%, respectively; p=0.04 and 0.03, respectively). There was no statistically significant difference in haemoptysis between the haemocoagulase (6%) and non-haemocoagulase (2%) groups (p=0.23). There were also no statistically significant associations of pneumothorax or pulmonary haemorrhage with the patients' positions, lesion location, or pathological results. CONCLUSION Biopsy tract haemocoagulase injection reduced the incidences of postoperative pneumothorax and pulmonary haemorrhage after PTLB.
Collapse
Affiliation(s)
- S Zhou
- Department of Radiology, Chongqing General Hospital, Chongqing 400014, China
| | - F Luo
- Department of Gastroenterology, The Chongqing Traditional Chinese Medicine Hospital, Chongqing Academy of Traditional Chinese Medicine, Chongqing 400021, China
| | - M Gu
- Department of Radiology, Chongqing General Hospital, Chongqing 400014, China
| | - X Lu
- Department of Radiology, Chongqing General Hospital, Chongqing 400014, China
| | - Y Xu
- Department of Radiology, Chongqing General Hospital, Chongqing 400014, China
| | - R Wu
- Department of Radiology, Chongqing General Hospital, Chongqing 400014, China
| | - J Xiong
- Institute of Higher Education, Chongqing Medical and Pharmaceutical College, Chongqing 401334, China
| | - X Ran
- Department of Radiology, Chongqing General Hospital, Chongqing 400014, China.
| |
Collapse
|
13
|
Wang L, Wang L, Zhang Y, Zhao Z, Liu C, Li M, Liu J, Wang S, Yang D, Luo F, Yan J. LS-HB-Mediated Photodynamic Therapy Inhibits Proliferation and Induces Cell Apoptosis in Melanoma. Mol Pharm 2022; 19:2607-2619. [PMID: 35485954 DOI: 10.1021/acs.molpharmaceut.2c00302] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
Chlorin e6-C-15-ethyl ester (LS-HB), a newly identified photosensitizer, was isolated from chlorin e6. The mechanism of tumor cell death induced by photodynamic therapy with LS-HB (LS-HB-PDT) is still unknown. Here, we investigated the photophysical properties of LS-HB, evaluated the antitumor effect on melanoma in vitro and in vivo, and explored its possible mechanisms. LS-HB not only has an optimal spectral band of red wavelength (660 nm) for photosensitization but also has favorable photostability. More importantly, LS-HB-PDT elicited a potent dose-dependent phototoxic effect in vitro. We discovered that LS-HB located in the mitochondria of B16F10 cells was able to generate excess reactive oxygen species, which subsequently resulted in mitochondrial membrane potential loss and induced apoptosis via caspase-9 and caspase-3 pathways. Moreover, PDT with LS-HB markedly inhibited the growth of melanoma in vivo. Therefore, LS-HB is expected to be an effective potential photosensitizer in antitumor therapy.
Collapse
Affiliation(s)
- Lanlan Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Li Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Yang Zhang
- Fuzhou Neuro-Psychiatric Hospital Affiliated to Fujian Medical University, Fuzhou, Fujian 350008, China
| | - Zhiyu Zhao
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Cong Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Mengqi Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Jiajing Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Dong Yang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China
| |
Collapse
|
14
|
Wang L, Wang L, Xu P, Liu C, Wang S, Luo X, Li M, Liu J, Zhao Z, Lai W, Luo F, Yan J. pH-Responsive Liposomes Loaded with Targeting Procoagulant Proteins as Potential Embolic Agents for Solid Tumor-Targeted Therapy. Mol Pharm 2022; 19:1356-1367. [PMID: 35420039 DOI: 10.1021/acs.molpharmaceut.1c00912] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Selectively inducing tumor thrombosis and subsequent necrosis is a novel and promising antitumor strategy. We have previously designed a targeting procoagulant protein, called tTF-EG3287, which is a fusion of a truncated tissue factor (tTF) with EG3287, a short peptide against the neuropilin-1 (NRP1) binding site of vascular endothelial growth factor-A 165 (VEGF-A 165). However, off-target effects and high-dose requirements limit the further use of tTF-EG3287 in antitumor therapy. Therefore, we encapsulated tTF-EG3287 into poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine (PEOz-DSPE)-modified liposomes to construct pH-responsive liposomes as a novel vascular embolization agent, called tTF-EG3287@Liposomes. The liposomes had an average particle size of about 100 nm and showed considerable drug-loading capacity, encapsulation efficiency, and biocompatibility. Under the stimulation of acidic microenvironments (pH 6.5), the lipid membrane of tTF-EG3287@Liposomes collapsed, and the cumulative drug release rate within 72 h was 83 ± 1.26%. When administered to a mouse model of hepatocellular carcinoma (HCC), tTF-EG3287@Liposomes showed prolonged retention and enhanced accumulation in the tumor as well as a superior antitumor effec, compared with tTF-EG3287. This study demonstrates the potential of tTF-EG3287@Liposomes as a novel embolic agent for solid tumors and provides a new strategy for tumor-targeted infarction therapy.
Collapse
Affiliation(s)
- Li Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Lanlan Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Peilan Xu
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Cong Liu
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Shengyu Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Xian Luo
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Mengqi Li
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Jiajing Liu
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Zhiyu Zhao
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Weisong Lai
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Fanghong Luo
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| | - Jianghua Yan
- Cancer Research Center, Medical College, Xiamen University, Xiamen 361102, China
| |
Collapse
|
15
|
Luo F, Zhang K, Li G, Sun J. Leiomyoma of uncinate process of pancreas: A case report. Asian J Surg 2022; 45:1198-1199. [DOI: 10.1016/j.asjsur.2022.01.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2021] [Accepted: 01/07/2022] [Indexed: 11/02/2022] Open
|
16
|
Liu Z, Wang P, Xie F, Chen J, Cai M, Li Y, Yan J, Lin Q, Luo F. Virus-Inspired Hollow Mesoporous Gadolinium-Bismuth Nanotheranostics for Magnetic Resonance Imaging-Guided Synergistic Photodynamic-Radiotherapy. Adv Healthc Mater 2022; 11:e2102060. [PMID: 34894092 DOI: 10.1002/adhm.202102060] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Revised: 11/23/2021] [Indexed: 12/25/2022]
Abstract
The anti-tumor efficacy of single photodynamic therapy (PDT) and radiotherapy (RT) has been greatly affected by inadequate tumor uptake of photo/radiation sensitizers, limited laser penetration depth, and radiation sickness caused by high doses of X-rays. Here, the authors report a biomimetic coronavirus-inspired hollow mesoporous gadolinium/bismuth nanocarrier loaded with a new NIR photosensitizer HB (termed as HB@VHMBi-Gd) for magnetic resonance imaging (MRI)-guided synergistic photodynamic-RT. HB@VHMBi-Gd displayed a faster cellular uptake rate than the conventional spherical HMBi-Gd loaded with HB (HB@SHMBi-Gd) because of rough surface-enhanced adhesion. After intravenous injection, HB@VHMBi-Gd is efficiently delivered to the tumor and rapidly invades the tumor cells by surface spikes. Interestingly, lysosomal acidity can trigger the degradation of VHMBi-Gd to produce ultrasmall nanoparticles to amplify the X-ray attenuation ability and enhance MRI contrast and radiosensitization. Under laser and X-ray irradiation, HB@VHMBi-Gd significantly enhances 1 O2 generation from HB to induce activation of caspase 9/3 and inhibition of C-myc, while enhancing hydroxyl radical generation from Bi2 O3 to induce intense DNA breakage. By synergistically inducing cell apoptosis by distinct reactive oxygen species (ROS), HB@VHMBi-Gd exhibits superior anticancer efficacy with ≈90% tumor inhibition. They envision that biomimetic virus-inspired hollow hybrid metal nanoparticles can provide a promising strategy for imaging-guided synergistic photodynamic-RT.
Collapse
Affiliation(s)
- Zongjunlin Liu
- Cancer Research Center School of Medicine Xiamen University Xiamen 361000 P. R. China
| | - Peiyuan Wang
- Key Laboratory of Design and Assembly of Functional Nanostructures Fujian Institute of Research on the Structure of Matter Chinese Academy of Sciences Fuzhou 350007 P. R. China
- Xiamen Institute of Rare Earth Materials Institute of Haixi Chinese Academy of Sciences Xiamen 361000 P. R. China
| | - Fang Xie
- Department of Radiation Oncology Xiamen Cancer Center Xiamen Key Laboratory of Radiation Oncology The First Affiliated Hospital of Xiamen University School of Medicine Xiamen University Xiamen 361000 P. R. China
| | - Jianhao Chen
- Department of Radiation Oncology Xiamen Cancer Center Xiamen Key Laboratory of Radiation Oncology The First Affiliated Hospital of Xiamen University School of Medicine Xiamen University Xiamen 361000 P. R. China
| | - Meimei Cai
- Department of Radiation Oncology Xiamen Cancer Center Xiamen Key Laboratory of Radiation Oncology The First Affiliated Hospital of Xiamen University School of Medicine Xiamen University Xiamen 361000 P. R. China
| | - Yang Li
- Key Laboratory of Design and Assembly of Functional Nanostructures Fujian Institute of Research on the Structure of Matter Chinese Academy of Sciences Fuzhou 350007 P. R. China
- Xiamen Institute of Rare Earth Materials Institute of Haixi Chinese Academy of Sciences Xiamen 361000 P. R. China
| | - Jianghua Yan
- Cancer Research Center School of Medicine Xiamen University Xiamen 361000 P. R. China
| | - Qin Lin
- Department of Radiation Oncology Xiamen Cancer Center Xiamen Key Laboratory of Radiation Oncology The First Affiliated Hospital of Xiamen University School of Medicine Xiamen University Xiamen 361000 P. R. China
| | - Fanghong Luo
- Cancer Research Center School of Medicine Xiamen University Xiamen 361000 P. R. China
| |
Collapse
|
17
|
Huang Y, Guo FZ, Dai S, Hu HY, Fu SY, Liu JW, Luo F. Clinical insights into cisplatin-induced arrhythmia in a patient with locally advanced non-small cell lung cancer: a case report. Eur Rev Med Pharmacol Sci 2022; 26:6-10. [PMID: 35049014 DOI: 10.26355/eurrev_202201_27741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
OBJECTIVE Cardiotoxicity is a common adverse effect of many antineoplastic agents, including anthracyclines and paclitaxel. However, it has not been defined as a causal side effect of cisplatin. Here we report on a patient with locally advanced non-small cell lung cancer who developed a cardiotoxic event induced by cisplatin that manifested primarily as arrhythmia. MATERIALS AND METHODS Intensive cardiac monitoring through electrocardiogram was performed to estimate the severity degree and clinical condition of arrhythmia. RESULTS The frequency and severity of the arrhythmia had a strong temporal relationship with the administration of cisplatin, that made it likely that cisplatin was responsible for the cardiotoxicity observed. CONCLUSIONS In the present case report, we discuss the potential factors that may provide pivotal contributions to the patient's susceptibility to cardiotoxicity and review the published studies regarding the cardiotoxic influence of cisplatin. We also outline the critical points that oncologists should be aware of when dealing with such high-risk patients.
Collapse
Affiliation(s)
- Y Huang
- Lung Cancer Center, Cancer Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
| | | | | | | | | | | | | |
Collapse
|
18
|
Luo F, Su Y, Zhang Z, Li J. Bone marrow mesenchymal stem cells promote the progression of prostate cancer through the SDF-1/CXCR4 axis in vivo and vitro. Clin Transl Oncol 2021; 24:892-901. [PMID: 34855138 DOI: 10.1007/s12094-021-02740-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2021] [Accepted: 11/22/2021] [Indexed: 11/28/2022]
Abstract
PURPOSE The aim of this study was to investigate the involvement of the SDF-1/CXCR4 axis in the process of BMMSC homing in prostate cancer (PCa) in vivo and in vitro. METHODS After verification of BMMSCs, we fixed the concentration gradient of SDF-1 for BMMSC cultivation to analyze CXCR4 expression by qRT-PCR and flow cytometric analysis. Furthermore, we developed a non-contact co-culture system and explored the participation of the SDF-1/CXCR4 axis in PCa using qRT-PCR, flow cytometry, and ELISA. In addition, A green fluorescent protein (GFP)-transplanted methylnitrosourea (MNU)-induced PCa mouse model was established to investigate the CXCR4 expression in vivo. RESULTS The CXCR4 expression was up-regulated with the increase in SDF-1 concentrations, and elevated SDF-1 had a significant promoting effect on cell proliferation and migration in BMMSCs. Moreover, the CXCR4 expression of BMMSCs was significantly increased in the non-contact co-culture model with vascular endothelial cells (VECs), and analysis of this model also showed that the proliferation and migration of BMMSCs were promoted in the presence of VECs. The ELISA assay showed that the SDF-1 levels in the co-culture model at 48 h were significantly increased. Twenty of the GFP-transplanted mice were divided into a PCa group and a control group, and four GFP-transplanted mice were observed to have prostate tumorigenesis. It also showed that CXCR4 was obviously increased in the prostate tissue of PCa mice. CONCLUSION Our findings suggest that BMMSCs could home and promote the proliferation and migration of PCa through the SDF-1/CXCR4 axis in vivo and in vitro.
Collapse
Affiliation(s)
- F Luo
- The Institute of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, China
| | - Y Su
- The Institute of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, China
| | - Z Zhang
- The Institute of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, China
| | - J Li
- The Institute of Translational Medicine, Tianjin Union Medical Center of Nankai University, Tianjin, China.
| |
Collapse
|
19
|
Huang DL, Li CP, Wang JB, Luo F, Chen ZJ, Zhu ZB, Lai HY, Cai QX, Chen J. [Correlational verification of drug-induced liver injury with HLA-B*35:01 allele due to Polygonum multiflorum]. Zhonghua Gan Zang Bing Za Zhi 2021; 29:1106-1108. [PMID: 34933431 DOI: 10.3760/cma.j.cn501113-20210702-00312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
In order to verify the correlation between Polygonum multiflorum-induced liver injury and HLA-B*35 : 01 alleles, six hospitalized patients diagnosed with Polygonum multiflorum-induced liver injury (PM-DILI) were selected, and their clinicopathological data were collected. Simultaneously, blood HLA-B* 35 : 01 allele detection was performed. Among the six PM-DILI cases, 4 were male, aged 38.83 ± 10.13 years old. The types of liver injury were hepatocellular injury types in all, and the severity of liver injury in five cases was grade 3. The histological presentations were acute hepatitis and acute cholestatic hepatitis. PM-DILI cases were all HLA-B*35:01 carriers, with a carrier rate of 100%. This finding indicates that PM-DILI is significantly correlated with HLA-B*35:01 alleles. Therefore, HLA-B*35 : 01 alleles can be used as an important predictive indicator for PM-DILI.
Collapse
Affiliation(s)
- D L Huang
- Department of Liver Diseases, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China
| | - C P Li
- Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410000, China
| | - J B Wang
- The Fifth Medical Center, General Hospital of PLA, Beijing 100000, China
| | - F Luo
- Department of Liver Diseases, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China
| | - Z J Chen
- Department of Liver Diseases, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China
| | - Z B Zhu
- Department of Liver Diseases, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China
| | - H Y Lai
- Department of Liver Diseases, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China
| | - Q X Cai
- Department of Liver Diseases, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China
| | - J Chen
- Department of Liver Diseases, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen 518100, China
| |
Collapse
|
20
|
Luo F, Smagris E, Fletcher JA, Cohen JC, Hobbs HH. Hypolipidemia associated with inactivation of TM6SF2 is due to decreased VLDL-lipids secretion. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3371] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
A missense variant in Transmembrane 6 Superfamily Member 2 [TM6SF2 (E167K)] is associated with reduced plasma lipid levels and protection from coronary atherosclerosis. The substitution of lysine for glutamate at residue 167 is associated with a marked decrease in TM6SF2 protein expression, consistent with a loss-of-function mutation. However the biological role of TM6SF2 is not known, and the mechanism(s) responsible for the hypolipidemia associated with mutation gene has not been fully defined. To elucidate the pathological mechanism for the hypolipidemia associated with TM6SF2 deficiency, we inactivated Tm6sf2 in mice and rats.
Methods
Tm6sf2−/− mice were generated as described previously. Two lines of Tm6sf2−/− rats with different frameshift mutations in exon 1 were generated using CRISPR/Cas9 technology. Primary hepatocytes were isolated from WT and Tm6sf2−/− mice for microscopy. Rats were fasted 16 or 4 hours and tissues were collected on ice for cell fractionation, and in liquid nitrogen for biochemical analyses. Frozen samples were stored at −80°C for subsequent analyses.
Result
In both mice and rats, inactivation of Tm6sf2 recapitulated the phenotype of humans with the E167K substitution: steatosis, reduced plasma lipid levels, and transaminitis. The phenotype was readily apparent in animals fed chow diets. Both species had reduced secretion of VLDL-TG, as determined by TRITON WR1399 injection, with no decrease in secretion of ApoB. Experiments in isolated perfused livers from WT and Tm6sf2−/− mice confirmed that the decreased TG secretion observed in intact animals reflected reduced TG secretion from the liver. Lipidomic analysis of the liver perfusates by by LC-MS indicated that secretion of cholesteryl esters, and phospholipids was also decreased in the KO animals. Taken together, these findings are consistent with a role for TM6SF2 in lipidation of ApoB-containing lipoproteins. To further elucidate the function of TM6SF2, we used fluorescence microscopy and cell fractionation to determine the subcellular localization of the protein. Microscopic analysis showed that TM6SF2 co-localized with ER and Golgi markers, but cell fractionation studies indicated that the protein is located primarily in the smooth ER. The ratio of TG to ApoB was lower in Golgi fractions from TM6sf2−/− rats than in corresponding fractions from WT animals.
Conclusions
Since the sequela of TM6SF2 inactivation are already apparent in the Golgi, we speculate that TM6SF2 promotes lipidation of VLDL in a pre-Golgi compartment. We are currently performing additional studies to further define the specific mechanism whereby TM6SF2 promotes lipidation of ApoB-containing lipoproteins.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): National Institutes of Health
Collapse
Affiliation(s)
- F Luo
- The Second Xiangya Hospital of Central South University, Department of Cardiovascular Medicine, Changsha, China
| | - E Smagris
- University of Texas Southwestern Medical Center, Department of Molecular Genetics, Dallas, United States of America
| | - J A Fletcher
- University of Texas Southwestern Medical Center, Center for Human Nutrition, Dallas, United States of America
| | - J C Cohen
- University of Texas Southwestern Medical Center, Internal Medicine, Dallas, United States of America
| | - H H Hobbs
- University of Texas Southwestern Medical Center, Department of Molecular Genetics, Dallas, United States of America
| |
Collapse
|
21
|
Luo X, Xie J, Zhou Z, Ma S, Wang L, Li M, Liu J, Wang P, Li Y, Luo F, Yan J. Virus-Inspired Gold Nanorod-Mesoporous Silica Core-Shell Nanoparticles Integrated with tTF-EG3287 for Synergetic Tumor Photothermal Therapy and Selective Therapy for Vascular Thrombosis. ACS Appl Mater Interfaces 2021; 13:44013-44027. [PMID: 34494427 DOI: 10.1021/acsami.1c11947] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
Synergetic therapy includes the combination of two or more conventional therapeutic approaches and can be used for tumor treatment by combining the advantages and avoiding the drawbacks of each type of treatment. In the present study, truncated tissue factor (tTF)-EG3287 fusion protein-encapsulated gold nanorod (GNR)-virus-inspired mesoporous silica core-shell nanoparticles (vinyl hybrid silica nanoparticles; VSNP) (GNR@VSNP-tTF-EG3287) were synthesized to achieve synergetic therapy by utilizing selective vascular thrombosis therapy (SVTT) and photothermal therapy (PTT). By integrating the targeted coagulation activity of tTF-EG3287 and the high tumor ablation effect of GNR@VSNP, local hyperthermia could induce a high percentage of apoptosis of vascular endothelial cells by using near-infrared light. This provided additional phospholipid sites for tTF-EG3287 and enhanced its procoagulant activity in vitro. In addition, the nanoparticles, which had unique topological viral structures, exhibited superior cellular uptake properties leading to significant antitumor efficacy. The in vivo antitumor results further demonstrated an interaction between SVTT and PTT, whereas the synergetic therapy (SVTT and PTT) achieved an enhanced effect, which was superior to the respective treatment efficacy of each modality or the additive effect of their individual efficacies. In summary, the synthesized GNR@VSNP-tTF-EG3287 exerted synergetic effects and enhanced the antitumor efficiency by avoiding multiple injections and suboptimal administration. These effects simultaneously affected both tumor blood supply and cancer cell proliferation. The data suggested that the integration of SVTT induced by tTF-EG3287 and PTT could provide potential strategies for synergetic tumor therapy.
Collapse
Affiliation(s)
- Xian Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361005, Republic of China
| | - Jun Xie
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361005, Republic of China
| | - Zonglang Zhou
- The 174th Clinic College of People's Liberation Army, Anhui Medical University, Hefei 230031, Republic of China
| | - Sihan Ma
- School of Energy, Xiamen University, Xiamen 361005, Republic of China
- Fujian Research Center for Nuclear, Xiamen 361002, Republic of China
| | - Li Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361005, Republic of China
| | - Mengqi Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361005, Republic of China
| | - Jiajing Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361005, Republic of China
| | - Peiyuan Wang
- Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, Republic of China
- Department of Translational Medicine, Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, Xiamen 361024, Republic of China
| | - Yang Li
- Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, Fuzhou 350002, Republic of China
- Department of Translational Medicine, Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, Xiamen 361024, Republic of China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361005, Republic of China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361005, Republic of China
| |
Collapse
|
22
|
Liu Z, Xie F, Xie J, Chen J, Li Y, Lin Q, Luo F, Yan J. New-generation photosensitizer-anchored gold nanorods for a single near-infrared light-triggered targeted photodynamic-photothermal therapy. Drug Deliv 2021; 28:1769-1784. [PMID: 34470548 PMCID: PMC8425697 DOI: 10.1080/10717544.2021.1960923] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
Traditional combined photodynamic and photothermal therapy (PDT/PTT) was limited in clinical treatment of cancer due to the exceptionally low drug delivery efficiency to tumor sites and the activation by laser excitation with different wavelengths. We have accidentally discovered that our synthesized chlorin e6-C-15-ethyl ester (HB, a new type of photosensitizer) be activated by a laser with an excitation wavelength of 660 nm. Herein, we utilized Au nanorods (AuNRs) as 660 nm-activated PTT carriers to be successively surface-functionalized with HB and tumor-targeting peptide cyclic RGD (cRGD) to develop HB-AuNRs@cRGD for single NIR laser-induced targeted PDT/PTT. The HB-AuNRs@cRGD could be preferentially accumulated within tumor sites and rapidly internalized by cancer cells. Thereby, the HB-AuNRs@cRGD could exhibit amplified therapeutic effects by producing both significant reactive oxygen species (ROS) and hyperthermia simultaneously under the guidance of fluorescence imaging. The tumor inhibition rate on ECA109 esophageal cancer model was approximately 77.04%, and the negligible systematic toxicity was observed. This study proposed that HB-AuNRs@cRGD might be a promising strategy for single NIR laser-induced and imaging-guided targeted bimodal phototherapy.
Collapse
Affiliation(s)
- Zongjunlin Liu
- School of Medicine, Anti-Cancer Center, Xiamen University, Xiamen, China
| | - Fang Xie
- Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Jun Xie
- School of Medicine, Anti-Cancer Center, Xiamen University, Xiamen, China
| | - Jianhao Chen
- Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Yang Li
- Xiamen Institute of Rare Earth Materials, Institute of Haixi, Chinese Academy of Sciences, Xiamen, China
| | - Qin Lin
- Department of Radiation Oncology, Xiamen Cancer Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
| | - Fanghong Luo
- School of Medicine, Anti-Cancer Center, Xiamen University, Xiamen, China
| | - Jianghua Yan
- School of Medicine, Anti-Cancer Center, Xiamen University, Xiamen, China
| |
Collapse
|
23
|
Lu H, Luo F, Zhang Q, Li J, Cai L. The Physicochemical Characteristic of Activated Carbon Based on Sludge and Preparation Method. NEPT 2021. [DOI: 10.46488/nept.2021.v20i03.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
To understand the features and best preparation of sludge activated carbon (SAC), and the pore structure, component, adsorption characteristics, and the yield rate of SAC, many tests have been carried out. The study illustrated that the pore structure was mostly mesopore and amorphous pore such as the ink bottle hole. In terms of different preparations to obtain SAC, the yield of SAC in sample No.1 achieved 88.09%. Using the preparation of ZnCl2 as an activator, the iodine adsorption value was significantly higher than other preparations. However, the content of quartz in sample No.1 achieved a maximum of 52.51%. Charcoal was detected in all samples except sample nos 9-12. The adsorption capacity of Cu(II) and Cd(II) reached a maximum of 600.02 mg.kg-1 and 383.2 mg.kg-1. The results showed an optimum preparation condition, which was by using the ZnCl2 as an activator, 2:1 as the impregnated ratio, 40% concentration in activator and at 400ºC reaction temperature could create rich pore structure and charcoal inside.
Collapse
|
24
|
Xie J, Zhou Z, Ma S, Luo X, Liu J, Wang S, Chen Y, Yan J, Luo F. Facile Fabrication of BiF 3: Ln (Ln = Gd, Yb, Er)@PVP Nanoparticles for High-Efficiency Computed Tomography Imaging. Nanoscale Res Lett 2021; 16:131. [PMID: 34390420 PMCID: PMC8364619 DOI: 10.1186/s11671-021-03591-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/15/2021] [Accepted: 08/10/2021] [Indexed: 06/13/2023]
Abstract
X-ray computed tomography (CT) has been widely used in clinical practice, and contrast agents such as Iohexol are often used to enhance the contrast of CT imaging between normal and diseased tissue. However, such contrast agents can have some toxicity. Thus, new CT contrast agents are urgently needed. Owing to the high atomic number (Z = 83), low cost, good biological safety, and great X-ray attenuation property (5.74 cm2 kg-1 at 100 keV), bismuth has gained great interest from researchers in the field of nano-sized CT contrast agents. Here, we synthesized BiF3: Ln@PVP nanoparticles (NPs) with an average particle size of about 380 nm. After coating them with polyvinylpyrrolidone (PVP), the BiF3: Ln@PVP NPs possessed good stability and great biocompatibility. Meanwhile, compared with the clinical contrast agent Iohexol, BiF3: Ln@PVP NPs showed superior in vitro CT imaging contrast. Subsequently, after in situ injection with BiF3: Ln@PVP NPs, the CT value of the tumor site after the injection was significantly higher than that before the injection (the CT value of the pre-injection and post-injection was 48.9 HU and 194.58 HU, respectively). The morphology of the gastrointestinal (GI) tract can be clearly observed over time after oral administration of BiF3: Ln@PVP NPs. Finally, the BiF3: Ln@PVP NPs were completely discharged from the GI tract of mice within 48 h of oral administration with no obvious damage to the GI tract. In summary, our easily synthesized BiF3: Ln@PVP NPs can be used as a potential clinical contrast agent and may have broad application prospects in CT imaging.
Collapse
Affiliation(s)
- Jun Xie
- Cancer Research Center, Medical College, Xiamen University, Xiamen, 361102, China
| | - Zonglang Zhou
- The 174th Clinical College of People's Liberation Army, Anhui Medical University, Hefei, 230032, China
| | - Sihan Ma
- College of Energy, Xiamen University, Xiamen, 361102, China
| | - Xian Luo
- Cancer Research Center, Medical College, Xiamen University, Xiamen, 361102, China
| | - Jiajing Liu
- Cancer Research Center, Medical College, Xiamen University, Xiamen, 361102, China
| | - Shengyu Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen, 361102, China
| | - Yuqiang Chen
- Cancer Research Center, Medical College, Xiamen University, Xiamen, 361102, China.
- The 174th Clinical College of People's Liberation Army, Anhui Medical University, Hefei, 230032, China.
| | - Jianghua Yan
- Cancer Research Center, Medical College, Xiamen University, Xiamen, 361102, China.
| | - Fanghong Luo
- Cancer Research Center, Medical College, Xiamen University, Xiamen, 361102, China.
| |
Collapse
|
25
|
Wang L, Wang L, Wang S, Zhou Z, Liu Z, Xu P, Luo X, Wu T, Luo F, Yan J. N2E4, a Monoclonal Antibody Targeting Neuropilin-2, Inhibits Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma via Suppressing FAK/Erk/HIF-1α Signaling. Front Oncol 2021; 11:657008. [PMID: 34336654 PMCID: PMC8319910 DOI: 10.3389/fonc.2021.657008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Accepted: 05/24/2021] [Indexed: 01/20/2023] Open
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with extremely limited treatment; the effective targeting strategy stays an urgent unmet need. Neuropilin-2 (NRP2), a multifunctional transmembrane non-tyrosine-kinase glycoprotein, enhances various signal transduction pathways to modulate cancer progression. However, the application value of NRP2 as a therapeutic target in pancreatic cancer is still unclear. Here, we detected the elevated NRP2 was associated with the poor prognosis of pancreas carcinoma. The mouse monoclonal antibody targeting NRP2 (N2E4) that could specifically bind to PDAC cells was developed. Moreover, N2E4 inhibits PDAC proliferation, migration, and invasion in vitro, and repressed growth and metastasis in vivo. Mechanistically, the effect of N2E4 was mainly related to the blocking of interaction between NRP2 with integrinβ1 to inhibit FAK/Erk/HIF-1a/VEGF signaling. Therefore, N2E4 has the potential for targeting therapy of PDAC. This study lays a foundation for the future development of NRP2-based targeted therapy for PDAC.
Collapse
Affiliation(s)
- Li Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Lanlan Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Shengyu Wang
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Zonglang Zhou
- The 174th Clinical College of People's Liberation Army, Anhui Medical University, Hefei, China
| | - Zongjunlin Liu
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Peilan Xu
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Xian Luo
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Ting Wu
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Fanghong Luo
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Jianghua Yan
- Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| |
Collapse
|
26
|
Zhou Z, Xie J, Ma S, Luo X, Liu J, Wang S, Chen Y, Yan J, Luo F. Construction of Smart Nanotheranostic Platform Bi-Ag@PVP: Multimodal CT/PA Imaging-Guided PDT/PTT for Cancer Therapy. ACS Omega 2021; 6:10723-10734. [PMID: 34056226 PMCID: PMC8153791 DOI: 10.1021/acsomega.1c00225] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Accepted: 04/09/2021] [Indexed: 05/11/2023]
Abstract
High-efficiency nanotheranostic agents with multimodal imaging guidance have attracted considerable interest in the field of cancer therapy. Herein, novel silver-decorated bismuth-based heterostructured polyvinyl pyrrolidone nanoparticles (NPs) with good biocompatibility (Bi-Ag@PVP NPs) were synthesized for accurate theranostic treatment, which can integrate computed tomography (CT)/photoacoustic (PA) imaging and photodynamic therapy/photothermal therapy (PDT/PTT) into one platform. The Bi-Ag@PVP NPs can enhance light absorption and achieve a better photothermal effect than bismuth NPs. Moreover, after irradiation under an 808 nm laser, the Bi-Ag@PVP NPs can efficiently induce the generation of reactive oxygen species (ROS), thereby synergizing PDT/PTT to exert an efficient tumor ablation effect both in vitro and in vivo. Furthermore, Bi-Ag@PVP NPs can also be employed to perform enhanced CT/PA imaging because of their high X-ray absorption attenuation and enhanced photothermal conversion. Thus, they can be utilized as a highly effective CT/PA imaging-guided nanotheranostic agent. In addition, an excellent antibacterial effect was achieved. After irradiation under an 808 nm laser, the Bi-Ag@PVP NPs can destroy the integrity of Escherichia coli, thereby inhibiting E. coli growth, which can minimize the risk of infection during cancer therapy. In conclusion, our study provides a novel nanotheranostic platform that can achieve CT/PA-guided PDT/PTT synergistic therapy and have potential antibacterial properties. Thus, this work provides an effective strategy for further broad clinical application prospects.
Collapse
Affiliation(s)
- Zonglang Zhou
- The
174th Clinic College of People’s Liberation Army, Anhui Medical University, Hefei 230031, China
- The
73rd Army Hospital of the Chinese People’s Liberation Army, Xiamen 361003, China
| | - Jun Xie
- School
of Medicine, Xiamen University, Xiamen 361005, China
| | - Sihan Ma
- College
of Energy, Xiamen University, Xiamen 361005, China
| | - Xian Luo
- School
of Medicine, Xiamen University, Xiamen 361005, China
| | - Jiajing Liu
- School
of Medicine, Xiamen University, Xiamen 361005, China
| | - Shengyu Wang
- School
of Medicine, Xiamen University, Xiamen 361005, China
| | - Yuqiang Chen
- The
174th Clinic College of People’s Liberation Army, Anhui Medical University, Hefei 230031, China
- The
73rd Army Hospital of the Chinese People’s Liberation Army, Xiamen 361003, China
| | - Jianghua Yan
- School
of Medicine, Xiamen University, Xiamen 361005, China
| | - Fanghong Luo
- School
of Medicine, Xiamen University, Xiamen 361005, China
| |
Collapse
|
27
|
Li W, Liu C, Huang Z, Shi L, Zhong C, Zhou W, Meng P, Li Z, Wang S, Luo F, Yan J, Wu T. AKR1B10 negatively regulates autophagy through reducing GAPDH upon glucose starvation in colon cancer. J Cell Sci 2021; 134:237788. [PMID: 33758077 DOI: 10.1242/jcs.255273] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Accepted: 03/12/2021] [Indexed: 12/17/2022] Open
Abstract
Autophagy is considered to be an important switch for facilitating normal to malignant cell transformation during colorectal cancer development. Consistent with other reports, we found that the membrane receptor Neuropilin1 (NRP1) is greatly upregulated in colon cancer cells that underwent autophagy upon glucose deprivation. However, the mechanism underlying NRP1 regulation of autophagy is unknown. We found that knockdown of NRP1 inhibits autophagy and largely upregulates the expression of aldo-keto reductase family 1 B10 (AKR1B10). Moreover, we demonstrated that AKR1B10 interacts with and inhibits the nuclear importation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and then subsequently represses autophagy. Interestingly, we also found that an NADPH-dependent reduction reaction could be induced when AKR1B10 interacts with GAPDH, and the reductase activity of AKR1B10 is important for its repression of autophagy. Together, our findings unravel a novel mechanism of NRP1 in regulating autophagy through AKR1B10.
Collapse
Affiliation(s)
- Wanyun Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Cong Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Zilan Huang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Lei Shi
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Chuanqi Zhong
- State Key Laboratory of Cellular Stress Biology, Innovation Center for Cellular Signaling Network, School of Life Sciences, Xiamen University, Xiamen 361000, China
| | - Wenwen Zhou
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Peipei Meng
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Zhenyu Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China
| | - Ting Wu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361000, China.,Department of Basic Medicine, School of Medicine, Xiamen University, Xiamen 361000, China.,Xiamen University Research Center of Retroperitoneal Tumor Committee of Oncology Society of Chinese Medical Association, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361000, China.,Joint Laboratory of Xiamen University School of Medicine and Shanghai Jiangxia Blood Technology Co., Ltd., Xiamen 361000, China
| |
Collapse
|
28
|
Fan P, Zhang D, Yang K, Zhang Y, Lu Y, Luo F, Tian T, Liu Y, Zhou X. Clinical genetics involved in monogenic forms of hypertension in Chinese patients with early-onset hypertension and hypokalemia. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Monogenic forms of hypertension are regarded as a group of conditions characterized by early-onset and resistant hypertension, electrolyte imbalance. These alterations stem from single mutations that lead to maladaptive excretion of potassium, and consequent hypokalemia.
Purpose
This study aimed to analyze genes involved in monogenic forms of hypertension and clinical features in Chinese patients with early-onset hypertension and hypokalemia.
Methods
A total of 129 unrelated Chinese patients (89 male and 40 females; average onset age of hypertension 25±5 years) with early-onset hypertension and hypokalemia. Patients with hypertension secondary to common causes, including renal disease and renovascular disease, aortic diseases, and obstructive sleep apnea were excluded. Genomic DNA were extracted from peripheral blood leucocytes of each subject. Using next-generation sequencing, we targeted and sequenced 42 genes related to monogenic forms of hypertension. All rare variants were confirmed by Sanger sequencing.
Results
We detected 63 rare variants in 23 genes in 52 patients (40.3%). The variants in genes associated with pseudohypoaldosteronism, familial aldosteronism, pheochromocytoma or paraganglioma, and pseudohyperaldosteronism accounted for 22.2%, 23.8%, 20.6% and 11.1% respectively. Patients with rare variants had a significantly lower serum potassium (2.94±0.21 vs. 3.30±0.24 mmol/L, P<0.001) and family history of hypertension (67.3% vs. 31.2%, P<0.001). During 24±7.9 months of follow-up, several complication occurred, including stroke in 22 patients, coronary heart disease in 10, and chronic renal failure in 10. Factors associated with stroke were carrying rare variants (HR=4.371, 95% CI: 1.709–11.181, P=0.002), systolic blood pressure (HR=1.015, 95% CI: 1.004–1.037, P=0.015).
Conclusions
This study revealed a wide genetic spectrum in Chinese patients with early-onset hypertension and hypokalemia. Genetic testing helps to differentiate the diagnosis of monogenic forms of hypertension in patients with hypertension and hypokalemia, and evaluates prognosis. Those patients carrying rare variants presented with a high risk of severe complications, stroke and needed close follow-up.
Figure 1
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): CAMS Innovation Fund for Medical Sciences; the National Key Research and Development Program of China
Collapse
Affiliation(s)
- P Fan
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - D Zhang
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - K.Q Yang
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - Y Zhang
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - Y.T Lu
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - F Luo
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - T Tian
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - Y.X Liu
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - X.L Zhou
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| |
Collapse
|
29
|
Fan P, Zhang D, Yang K, Zhang Y, Lu Y, Luo F, Tian T, Liu Y, Zhou X. Apparent mineralocorticoid excess caused by novel compound heterozygous mutations in HSD11B2. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2718] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Apparent mineralocorticoid excess (AME) is a rare autosomal recessive genetic disorder caused by a mutation in the 11β-hydroxysteroid dehydrogenase type 2 gene (HSD11B2). AME is characterized by early-onset and severe hypertension, hypokalemia, and metabolic alkalosis.
Purpose
This study aimed to study the molecular genetics, clinical presentation, biochemical parameters, and treatment in the proband with AME from a non-consanguineous Chinese family.
Methods
Genomic DNA was recovered from peripheral blood leukocytes from nine subjects in this family. Next-generation sequencing and Sanger sequencing were performed to identify the HSD11B2 variants. In silico and genotype-phenotype correlations analyses were used to predict pathogenicity of candidate variants. A tailored therapy was performed for identified mutations carriers.
Results
Genetic analysis identified novel compound heterozygous HSD11B2 mutations (c.343-348del/c.1099-1101del) in the proband. In silico analysis predicted these HSD11B2 mutations were deleterious. The structural change and predicted consequences owing to the compound mutations have been modeled. The same compound mutations were not found in any other family members, 100 hypertensives, or 100 healthy controls. The proband had typical manifestations of AME, including early-onset and severe hypertension, hypokalemia, low plasma aldosterone concentration, hypokalemic alkalosis and nephrolithiasis. The probands' blood pressure and serum potassium level had returned to normal after treatmennt with dexamethasone (1.5 mg/day) and spirolactone (40 mg/day) for three months.
Conclusions
We conclude that this novel compound mutations are responsible for AME in the proband. These genetic and clinical data expand the genetic spectrum of HSD11B2 and demonstrate the pathogenic effects of identified mutations and genotype-phenotype correlations. It is emphasized that genetic diagnosis and specific treatment play an important role in patients with AME.
Figure 1
Funding Acknowledgement
Type of funding source: Public grant(s) – National budget only. Main funding source(s): National Key Research and Development Program of China; PUMC Youth Fund and the Fundamental Research Funds for the Central Universities
Collapse
Affiliation(s)
- P Fan
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - D Zhang
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - K.Q Yang
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - Y Zhang
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - Y.T Lu
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - F Luo
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - T Tian
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - Y.X Liu
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| | - X.L Zhou
- Fuwai Hospital, CAMS and PUMC, Beijing, China
| |
Collapse
|
30
|
Xiang MY, Li J, Luo F, Sun CS, Zhu BK, Wang JP, Mo XJ, Zhang T, Xu B, Feng Z, Hu W. [Identification and functional study of the Schistosoma japonicum epidermal growth factor receptor gene]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 2020; 32:123-131. [PMID: 32458600 DOI: 10.16250/j.32.1374.2019300] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE To characterize the epidermal growth factor receptor (EGFR) gene in Schistosoma japonicum (SjEGFR gene) and investigate the role of the EGFR gene in regulating the growth, reproductive system, maturation and fecundity of S. japonicum. METHODS Rapid amplification of cDNA ends (RACE) was performed to obtain the full length of the SjEGFR gene, and the SjEGFR gene expression was quantified in different developmental stages of S. japonicum using a quantitative real-time PCR (qPCR) assay. The tissue localization of the SjEGFR gene was detected in 22-day parasite using whole-mount in situ hybridization (WISH). Following RNA interference (RNAi)-induced knockdown of the SjEGFR gene, the worm length, pairing rate and worm burden of S. japonicum were measured, and the worm morphology was observed using optical microscopy and confocal microscopy. RESULTS The SjEGFR gene was identified with a conserved tyrosine-kinase active site, and the SjEGFR gene expression was detected at various developmental stages in male and female parasites. WISH showed that the transcript of the SjEGFR gene was localized on the tegument and in the digestive organs of S. japonicum. RNAi-induced SjEGFR knockdown resulted in marked suppression of the worm growth, smaller size of male testicles that contained more immature spermatocytes, and apparent impairment of ovary and vitelline gland development. In addition, no eggs were found in the uterus of SjEGFR knocked-down female parasites, indicating the interruption of egg production. CONCLUSIONS Inhibition of SjEGFR expression may remarkably suppress the growth and maturation of S. japonicum, and interrupt the egg production.
Collapse
Affiliation(s)
- M Y Xiang
- State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering,Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Science, Fudan University, Shanghai 200433, China
| | - J Li
- State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering,Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Science, Fudan University, Shanghai 200433, China
| | - F Luo
- State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering,Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Science, Fudan University, Shanghai 200433, China
| | - C S Sun
- State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering,Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Science, Fudan University, Shanghai 200433, China
| | - B K Zhu
- State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering,Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Science, Fudan University, Shanghai 200433, China
| | - J P Wang
- State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering,Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Science, Fudan University, Shanghai 200433, China
| | - X J Mo
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Centre for Tropical Diseases, Joint Research Laboratory of Genetics and Ecology on Parasite-Host Interaction, Chinese Center for Disease Control and Prevention & Fudan University, China
| | - T Zhang
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Centre for Tropical Diseases, Joint Research Laboratory of Genetics and Ecology on Parasite-Host Interaction, Chinese Center for Disease Control and Prevention & Fudan University, China
| | - B Xu
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Centre for Tropical Diseases, Joint Research Laboratory of Genetics and Ecology on Parasite-Host Interaction, Chinese Center for Disease Control and Prevention & Fudan University, China
| | - Z Feng
- National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Centre for Tropical Diseases, Joint Research Laboratory of Genetics and Ecology on Parasite-Host Interaction, Chinese Center for Disease Control and Prevention & Fudan University, China
| | - W Hu
- State Key Laboratory of Genetic Engineering, Ministry of Education Key Laboratory for Biodiversity Science and Ecological Engineering,Ministry of Education Key Laboratory of Contemporary Anthropology, School of Life Science, Fudan University, Shanghai 200433, China.,National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Key Laboratory of Parasite and Vector Biology, National Health Commission, WHO Collaborating Centre for Tropical Diseases, Joint Research Laboratory of Genetics and Ecology on Parasite-Host Interaction, Chinese Center for Disease Control and Prevention & Fudan University, China
| |
Collapse
|
31
|
Zou M, Xu P, Wang L, Wang L, Li T, Liu C, Shi L, Xie J, Li W, Wang S, Wu G, Luo F, Wu T, Yan J. Design and construction of a magnetic targeting pro-coagulant protein for embolic therapy of solid tumors. Artif Cells Nanomed Biotechnol 2020; 48:116-128. [PMID: 31852257 DOI: 10.1080/21691401.2019.1699817] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
In this study, we have designed a magnetic targeting pro-coagulant protein (MTPCP) for the embolic therapy of solid tumours. The MTPCP consists of a magnetic carrier and a pro-coagulant protein. The pro-coagulant protein used in this study is the fusion protein tTF-EG3287 which is not pro-coagulant when free in the blood circulation, but presents strong pro-coagulant ability once bound to the Neuropilin-1(NRP-1) that is highly expressed on tumour-associated vascular endothelial cells. And the magnetic carrier is O-Carboxymethyl chitosan-coated iron oxide nanoparticles (OCMC/Fe3O4). In vitro, we assessed the NRP-1 targeting ability of the MTPCP using confocal microscopy and flow cytometry, and evaluated the potential pro-coagulant activity of the MTPCP using the Spectozyme FXa assay. In vivo, the magnetic targeting ability of the MTPCP was detected using a living imaging system. At last, we assessed the anticancer activity of the MTPCP on HepG2 tumour bearing BALB/c nude mice models including subcutaneous transplantation and orthotopic transplantation. HepG2 tumour bearing mice models revealed that after intravenous administration of the MTPCP, thrombosis specifically occurs on tumour-associated blood vessels, and resulting in tumour growth retardation. No apparent side effects, such as thrombosis in other organs or other treatment-related toxicity, were observed during the treatment. Our data showed that the MTPCP may be a promising embolic agent for the embolic therapy of solid tumours.
Collapse
Affiliation(s)
- Mingyuan Zou
- Medical School of Southeast University, Nanjing, Jiangsu, China.,Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Peilan Xu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Li Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Lanlan Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Tingting Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Cong Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Lei Shi
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Jun Xie
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Wanyun Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Guoqiu Wu
- Center of Clinical Laboratory Medicine, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Ting Wu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| |
Collapse
|
32
|
Yaqoob U, Luo F, Greuter T, Jalan Sakrikar N, Sehrawat TS, Lu J, Hu X, Gao J, Kostallari E, Chen J, Arab JP, Martin-Mateos R, Cao S, Shah VH. GIPC-Regulated IGFBP-3 Promotes HSC Migration In Vitro and Portal Hypertension In Vivo Through a β1-Integrin Pathway. Cell Mol Gastroenterol Hepatol 2020; 10:545-559. [PMID: 32447051 PMCID: PMC7399184 DOI: 10.1016/j.jcmgh.2020.05.005] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Revised: 05/13/2020] [Accepted: 05/14/2020] [Indexed: 12/17/2022]
Abstract
BACKGROUND & AIMS Transforming growth factor (TGF-β)-induced activation of quiescent hepatic stellate cells (HSCs) and their transformation to myofibroblasts is a key event in liver fibrosis and portal hypertension. GIPC (also referred to as synectin) is a downstream signal activation molecule of TGF-β and other receptors. In this study, we sought to identify novel genes targeted by TGF-β and GIPC and elucidate if and how they may contribute to liver fibrosis. METHODS We performed sequential messenger RNA sequencing analysis on TGF-β-stimulated HSCs and then on TGF-β-stimulated HSCs in the presence and absence of GIPC also referred to as synectin (GIPC) knockdown. Insulin-like growth factor binding protein-3 (IGFBP-3) transport protein emerged as a top activation target of both TGF-β and GIPC. Quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, targeted chromatin immunoprecipitation, and Western blot analysis were done for further confirmation. RESULTS IGFBP-3, an insulin growth factor transport protein, emerged as a top activation target of both TGF-β and GIPC, which was confirmed by quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, and Western blot analysis. Targeted chromatin immunoprecipitation showed that GIPC increases the histone 3 lysine 27 (H3K27) acetylation activating mark and concurrently decreases the H3K27 inhibitory trimethylation (H3K27m3) mark, providing an epigenetic correlate to the gene regulation changes. In vivo, global knockout of IGFBP-3 mice resulted in attenuation of HSC activation markers and attenuation of portal pressure in response to chronic liver injury models. Analysis of serum levels from cirrhotic patients also showed an IGFBP-3 increase of more than 2-fold compared with healthy controls. Finally, in vitro mechanism studies showed that IGFBP-3 promotes HSC migration through integrin-dependent phosphorylation of protein kinase B. CONCLUSIONS TGF-β up-regulates IGFBP-3 through GIPC, leading to increased HSC migration in vitro and promotes portal hypertension in vivo. These studies support the role of IGFBP-3 as a potential pathophysiologic target or biomarker in chronic liver disease.
Collapse
Affiliation(s)
- Usman Yaqoob
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Fanghong Luo
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota,Cancer Research Center, Medical College, Xiamen University, Xiamen, China
| | - Thomas Greuter
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota,Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
| | - Nidhi Jalan Sakrikar
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Tejasav S. Sehrawat
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Jianwen Lu
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Xiao Hu
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Jinhang Gao
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Enis Kostallari
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Jingbiao Chen
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Juan Pablo Arab
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
| | - Rosa Martin-Mateos
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota,Division of Gastroenterology and Hepatology, Ramón y Cajal University Hospital, Madrid, Spain
| | - Sheng Cao
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota,Correspondence Address correspondence to: Vijay H. Shah, MD, or Sheng Cao, MD, Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota 55905; fax: (507) 255-6318.
| | - Vijay H. Shah
- Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota,Correspondence Address correspondence to: Vijay H. Shah, MD, or Sheng Cao, MD, Gastroenterology Research Unit, Division of Gastroenterology and Hepatology, Mayo Clinic and Foundation, 200 First Street SW, Rochester, Minnesota 55905; fax: (507) 255-6318.
| |
Collapse
|
33
|
|
34
|
Zhao L, Luo F, Wang A, Zhang J, Wang Y, Zhao L, Wang Z, Pu Q. Quick stabilization of capillary for rapid determination of potassium ions in the blood of epilepsy patients by capillary electrophoresis without sample pretreatment. Electrophoresis 2020; 41:1273-1279. [PMID: 32358896 DOI: 10.1002/elps.202000022] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2020] [Revised: 04/21/2020] [Accepted: 04/23/2020] [Indexed: 11/07/2022]
Abstract
Mutations in the potassium channel genes may be linked to the development of epilepsy and affect the blood potassium levels. Therefore, accurate determination of potassium in the blood will be critical to diagnose the cause of epilepsy. CE is a competent technique for the fast detection of multiple ions, but complicated matrices of a blood sample may cause significant variation of migration times and the peak shape. In this work, a procedure for rapid stabilization of the capillary inner surface through preflushing of a blood sample was employed. The process takes only 40 min for a capillary and then it can be used for more than 2 weeks. No pretreatment of the blood sample or other surface modification of the capillary is needed for the analysis. The RSDs of the migration time and peak area were reduced to 1.5 and 5.1% from 12.6 and 14.5%, respectively. The proposed method has been successfully applied to the determination of the potassium contents in the blood sample of patients with epilepsy at different stages. The recoveries of potassium ions in these blood samples are in a range from 86.5 to 104.5%.
Collapse
Affiliation(s)
- Litao Zhao
- School of Pharmacy, Lanzhou University, Lanzhou, P. R. China
| | - Fanghong Luo
- School of Pharmacy, Lanzhou University, Lanzhou, P. R. China
| | - Anting Wang
- School of Pharmacy, Lanzhou University, Lanzhou, P. R. China
| | - Jing Zhang
- School of Pharmacy, Lanzhou University, Lanzhou, P. R. China
| | - Yuanhang Wang
- College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, P. R. China
| | - Liangtao Zhao
- TSing Biomedical Research Center, The Second Hospital of Lanzhou University, Lanzhou, P. R. China
| | - Zhaoyan Wang
- School of Pharmacy, Lanzhou University, Lanzhou, P. R. China
| | - Qiaosheng Pu
- College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, P. R. China
| |
Collapse
|
35
|
Zhu M, Luo F. The Accuracy Comparison of Bronchiectasis Severity Index and Faced Score in Patients with Bronchiectasis. D104. PHENOTYPES, PROGNOSTIC TOOLS, AND ADJUNCT THERAPIES IN COUGH, CF AND NON-CF BRONCHIECTASIS 2020. [DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- M. Zhu
- Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China
| | - F. Luo
- Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China
| |
Collapse
|
36
|
Luo F, Tany Y, Sun H, Liu J, Sheng L. Study Frequency Shift Evaluation of Ultrasound in Fresh and Frozen-thawed Tissues of Cryosurgery by AR Model. Cryo Letters 2020; 41:140-144. [PMID: 33988643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Abstract
BACKGROUND Noninvasive monitoring of cryosurgery is important for performing precise monitoring of the freezing process in situ and evaluating postoperative effects after therapy. One potential approach is to monitor the normal and freeze-thawed tissues through ultrasonic backscattered signal processing. OBJECTIVE A noninvasive method for cryosurgery monitoring based on the analysis of microstructural characteristics of in vitro porcine liver tissues at different state including normal and freeze-thawed tissues by estimating the center frequency of scatterers (CFS) using the autoregressive (AR) cepstrum of ultrasonic backscattered signals. MATERIALS AND METHODS The method is based on the discrete scattering model described in the tissue characterization literature and the observation that most biological tissues are semi-regular scattering lattices. A total of ten in vitro porcine liver samples were used and freeze by water bath in the experiments. RESULTS Experimental results show that the CFS in porcine liver tissues decreases after pre-frozen and then thawed. CONCLUSION The CFS obtained using this method may be used as a characteristic parameter for tissue characterization in noninvasive monitoring the transition zone between frozen and unfrozen tissues during the surgical therapy, and evaluating postoperative effects.
Collapse
Affiliation(s)
- F Luo
- Beijing Key Laboratory of Pre-clinical Research and Evaluation for Cardiovascular Implant Materials, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - Y Tany
- Beijing Key Laboratory of Pre-clinical Research and Evaluation for Cardiovascular Implant Materials, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
| | - H Sun
- Center of Cardiac Surgery for Adults, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Centre for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
| | - J Liu
- Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China
| | - L Sheng
- Key Laboratory of Cryogenics, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China.
| |
Collapse
|
37
|
Liu C, Wu T, Wang S, Zhou W, Li Y, Chen X, Li W, Huang Z, Li T, Yang L, Xu P, Liuzong J, Xie J, Yang D, Yan J, Luo F. Anticancer effect of LS-HB-mediated photodynamic therapy on hepatocellular carcinoma in vitro and in vivo. Photodiagnosis Photodyn Ther 2020; 30:101718. [PMID: 32165340 DOI: 10.1016/j.pdpdt.2020.101718] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2019] [Revised: 03/04/2020] [Accepted: 03/06/2020] [Indexed: 12/29/2022]
Abstract
Photodynamic therapy (PDT) is a relatively safe way for disease diagnosis and treatment that is based on light and photosensitizers. LS-HB is a promising photosensitizer with a light absorption peak of 660 nm. AIMS The present study aimed to investigate the anticancer effects of LS-HB-PDT on hepatocellular carcinoma and its underlying molecular mechanism. METHODS In the present study, the MTT assay and xenograft tumor model experiment were used to evaluate its anticancer effects as well as its dark toxicity in hepatocellular carcinoma in vitro and in vivo. Reactive oxygen species assay kit was utilized to detect the reactive oxygen species production induced by LS-HB-PDT. RESULTS In vitro, the MTT assay results revealed that LS-HB-PDT exhibited significant cytotoxic effects both in a drug- and light dose-dependent manner. The IC50 of LS-HB-PDT on hepatocellular carcinoma cells was 2.685 μg/ml. However, no dark cytotoxicity was observed at the LS-HB concentrations of 0-50 μg/ml, and no light-induced cytotoxicity was observed at the light (660 nm) dosages of 0-40 J/cm2. Furthermore, reactive oxygen species could be induced after LS-HB-PDT in a drug- and light dose-dependent manner. In vivo experiment, the tumor inhibition ratio of tumor-bearing nude mice following LS-HB-PDT was enhanced with the drug and light dose increasing. Notably, tumors in 60.0% of mice disappeared after LS-HB-PDT (2 mg/kg; 100 J/cm2), and the tumor inhibition ratio reached 92.3%. Furthermore, the histological results revealed necrosis and thrombus in tumor tissue caused by LS-HB-PDT, which were not observed in the control, drug alone and light alone groups of mice. CONCLUSIONS The present study indicated that LS-HB was a promising photosensitizer with excellent anticancer effects and low side effects. LS-HB-PDT induced reactive oxygen species damage in the cells directly and destroyed tumor blood vessels, thus leading to tumor tissue necrosis.
Collapse
Affiliation(s)
- Cong Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Ting Wu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Wenwen Zhou
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Yangxin Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Xiaoli Chen
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Wanyun Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Zilan Huang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Tingting Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Liu Yang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Peilan Xu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Junlin Liuzong
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Jun Xie
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China
| | - Dong Yang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China.
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China.
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, 361102, China.
| |
Collapse
|
38
|
Luo F, Fan Z, Yin W, Yang L, Li T, Zhong L, Li Y, Wang S, Yan J, Hou Z, Zhang Q. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy. Materials Science and Engineering: C 2019; 105:110107. [DOI: 10.1016/j.msec.2019.110107] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/19/2019] [Revised: 08/05/2019] [Accepted: 08/20/2019] [Indexed: 10/26/2022]
|
39
|
Aguilar M, Ali Cavasonza L, Ambrosi G, Arruda L, Attig N, Bachlechner A, Barao F, Barrau A, Barrin L, Bartoloni A, Başeğmez-du Pree S, Battiston R, Becker U, Behlmann M, Beischer B, Berdugo J, Bertucci B, Bindi V, de Boer W, Bollweg K, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Cai XD, Capell M, Caroff S, Casaus J, Castellini G, Cervelli F, Chang YH, Chen GM, Chen HS, Chen Y, Cheng L, Chou HY, Choutko V, Chung CH, Clark C, Coignet G, Consolandi C, Contin A, Corti C, Cui Z, Dadzie K, Dai YM, Datta A, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Di Felice V, Díaz C, Dimiccoli F, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Feng J, Fiandrini E, Fisher P, Formato V, Galaktionov Y, Gámez C, García-López RJ, Gargiulo C, Gast H, Gebauer I, Gervasi M, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Guo KH, Haino S, Han KC, He ZH, Hsieh TH, Huang H, Huang ZC, Incagli M, Jang WY, Jia Y, Jinchi H, Kanishev K, Khiali B, Kim GN, Kirn T, Konyushikhin M, Kounina O, Kounine A, Koutsenko V, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Li JQ, Li Q, Li TX, Li ZH, Light C, Lin CH, Lippert T, Liu Z, Lu SQ, Lu YS, Luebelsmeyer K, Luo F, Luo JZ, Luo X, Lyu SS, Machate F, Mañá C, Marín J, Martin T, Martínez G, Masi N, Maurin D, Menchaca-Rocha A, Meng Q, Mo DC, Molero M, Mott P, Mussolin L, Nelson T, Ni JQ, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Paniccia M, Pashnin A, Pauluzzi M, Pensotti S, Phan HD, Plyaskin V, Poireau V, Poluianov S, Popkow A, Qi XM, Qin X, Qu ZY, Quadrani L, Rancoita PG, Rapin D, Reina Conde A, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Schael S, Schmidt SM, Schulz von Dratzig A, Schwering G, Seo ES, Shan BS, Shi JY, Siedenburg T, Solano C, Song JW, Sun ZT, Tacconi M, Tang XW, Tang ZC, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Tüysüz C, Urban T, Usoskin I, Vagelli V, Vainio R, Valente E, Valtonen E, Vázquez Acosta M, Vecchi M, Velasco M, Vialle JP, Wang LQ, Wang NH, Wang QL, Wang X, Wang XQ, Wang ZX, Wei J, Weng ZL, Wu H, Xiong RQ, Xu W, Yan Q, Yang Y, Yi H, Yu YJ, Yu ZQ, Zannoni M, Zeissler S, Zhang C, Zhang F, Zhang JH, Zhang Z, Zhao F, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zimmermann N, Zuccon P. Properties of Cosmic Helium Isotopes Measured by the Alpha Magnetic Spectrometer. Phys Rev Lett 2019; 123:181102. [PMID: 31763896 DOI: 10.1103/physrevlett.123.181102] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 10/02/2019] [Indexed: 06/10/2023]
Abstract
Precision measurements by the Alpha Magnetic Spectrometer (AMS) on the International Space Station of ^{3}He and ^{4}He fluxes are presented. The measurements are based on 100 million ^{4}He nuclei in the rigidity range from 2.1 to 21 GV and 18 million ^{3}He from 1.9 to 15 GV collected from May 2011 to November 2017. We observed that the ^{3}He and ^{4}He fluxes exhibit nearly identical variations with time. The relative magnitude of the variations decreases with increasing rigidity. The rigidity dependence of the ^{3}He/^{4}He flux ratio is measured for the first time. Below 4 GV, the ^{3}He/^{4}He flux ratio was found to have a significant long-term time dependence. Above 4 GV, the ^{3}He/^{4}He flux ratio was found to be time independent, and its rigidity dependence is well described by a single power law ∝R^{Δ} with Δ=-0.294±0.004. Unexpectedly, this value is in agreement with the B/O and B/C spectral indices at high energies.
Collapse
Affiliation(s)
- M Aguilar
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - L Ali Cavasonza
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - G Ambrosi
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - L Arruda
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1000 Lisboa, Portugal
| | - N Attig
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, 52425 Jülich, Germany
| | - A Bachlechner
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - F Barao
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1000 Lisboa, Portugal
| | - A Barrau
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - L Barrin
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | | | - S Başeğmez-du Pree
- KVI-Center for Advanced Radiation Technology, University of Groningen, 9700 AB Groningen, The Netherlands
| | - R Battiston
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| | - U Becker
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Behlmann
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - B Beischer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - J Berdugo
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - B Bertucci
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - V Bindi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - W de Boer
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
| | - K Bollweg
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - B Borgia
- INFN Sezione di Roma 1, 00185 Roma, Italy
- Università di Roma La Sapienza, 00185 Roma, Italy
| | - M J Boschini
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
| | - M Bourquin
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - E F Bueno
- KVI-Center for Advanced Radiation Technology, University of Groningen, 9700 AB Groningen, The Netherlands
| | - J Burger
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | | | - X D Cai
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Capell
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - S Caroff
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - J Casaus
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | | | - Y H Chang
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan 32054, Taiwan
| | - G M Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - H S Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Y Chen
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - L Cheng
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - H Y Chou
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan 32054, Taiwan
| | - V Choutko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C H Chung
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Clark
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Coignet
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - C Consolandi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Contin
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - C Corti
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - Z Cui
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - K Dadzie
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y M Dai
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - A Datta
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C Delgado
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | - M B Demirköz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - L Derome
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | | | - V Di Felice
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - C Díaz
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | | | - P von Doetinchem
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Dong
- Southeast University (SEU), Nanjing 210096, China
| | - F Donnini
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - M Duranti
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - A Egorov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Eline
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J Feng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - E Fiandrini
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - P Fisher
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Formato
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - Y Galaktionov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C Gámez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - R J García-López
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - C Gargiulo
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - H Gast
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - I Gebauer
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
| | - M Gervasi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - F Giovacchini
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - D M Gómez-Coral
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - J Gong
- Southeast University (SEU), Nanjing 210096, China
| | - C Goy
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - V Grabski
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - D Grandi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - M Graziani
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
| | - K H Guo
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - S Haino
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - K C Han
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan 32546, Taiwan
| | - Z H He
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - T H Hsieh
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Huang
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - Z C Huang
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - M Incagli
- INFN Sezione di Pisa, 56100 Pisa, Italy
| | - W Y Jang
- CHEP, Kyungpook National University, 41566 Daegu, Korea
| | - Yi Jia
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Jinchi
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan 32546, Taiwan
| | | | - B Khiali
- INFN Sezione di Perugia, 06100 Perugia, Italy
| | - G N Kim
- CHEP, Kyungpook National University, 41566 Daegu, Korea
| | - Th Kirn
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - M Konyushikhin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - O Kounina
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kounine
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Koutsenko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kulemzin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - G La Vacca
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - E Laudi
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - G Laurenti
- INFN Sezione di Bologna, 40126 Bologna, Italy
| | - I Lazzizzera
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| | - A Lebedev
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H T Lee
- Academia Sinica Grid Center (ASGC), Nankang, Taipei 11529, Taiwan
| | - S C Lee
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - J Q Li
- Southeast University (SEU), Nanjing 210096, China
| | - Q Li
- Southeast University (SEU), Nanjing 210096, China
| | - T X Li
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - Z H Li
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - C Light
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C H Lin
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - T Lippert
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, 52425 Jülich, Germany
| | - Z Liu
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - S Q Lu
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - Y S Lu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - K Luebelsmeyer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - F Luo
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - J Z Luo
- Southeast University (SEU), Nanjing 210096, China
| | - Xi Luo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - S S Lyu
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - F Machate
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Mañá
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J Marín
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - T Martin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Martínez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - N Masi
- INFN Sezione di Bologna, 40126 Bologna, Italy
| | - D Maurin
- Université Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, 38000 Grenoble, France
| | - A Menchaca-Rocha
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - Q Meng
- Southeast University (SEU), Nanjing 210096, China
| | - D C Mo
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - M Molero
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - P Mott
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - L Mussolin
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - T Nelson
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - J Q Ni
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - N Nikonov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - F Nozzoli
- INFN TIFPA, 38123 Povo, Trento, Italy
| | - A Oliva
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - M Orcinha
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), 1000 Lisboa, Portugal
| | - M Palermo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Palmonari
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - M Paniccia
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - A Pashnin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Pauluzzi
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - S Pensotti
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - H D Phan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Plyaskin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Poireau
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - S Poluianov
- Sodankylä Geophysical Observatory and Space Climate Research Unit, University of Oulu, 90014 Oulu, Finland
| | - A Popkow
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - X M Qi
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - X Qin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Z Y Qu
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - L Quadrani
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - P G Rancoita
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
| | - D Rapin
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - A Reina Conde
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - S Rosier-Lees
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - A Rozhkov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - D Rozza
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - R Sagdeev
- East-West Center for Space Science, University of Maryland, College Park, Maryland 20742, USA
| | - S Schael
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - S M Schmidt
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, 52425 Jülich, Germany
| | - A Schulz von Dratzig
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - G Schwering
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - E S Seo
- IPST, University of Maryland, College Park, Maryland 20742, USA
| | - B S Shan
- Beihang University (BUAA), Beijing 100191, China
| | - J Y Shi
- Southeast University (SEU), Nanjing 210096, China
| | - T Siedenburg
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - C Solano
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - J W Song
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - Z T Sun
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - M Tacconi
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - X W Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - Z C Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - J Tian
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - Samuel C C Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- European Organization for Nuclear Research (CERN), 1211 Geneva 23, Switzerland
| | - S M Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - N Tomassetti
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - J Torsti
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - C Tüysüz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - T Urban
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - I Usoskin
- Sodankylä Geophysical Observatory and Space Climate Research Unit, University of Oulu, 90014 Oulu, Finland
| | - V Vagelli
- INFN Sezione di Perugia, 06100 Perugia, Italy
- Università di Perugia, 06100 Perugia, Italy
| | - R Vainio
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - E Valente
- INFN Sezione di Roma 1, 00185 Roma, Italy
- Università di Roma La Sapienza, 00185 Roma, Italy
| | - E Valtonen
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, 20014 Turku, Finland
| | - M Vázquez Acosta
- Instituto de Astrofísica de Canarias (IAC), 38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, 38206 La Laguna, Tenerife, Spain
| | - M Vecchi
- KVI-Center for Advanced Radiation Technology, University of Groningen, 9700 AB Groningen, The Netherlands
- Instituto de Física de São Carlos, Universidade de São Paulo, CP 369, 13560-970 São Carlos, São Paulo, SP, Brazil
| | - M Velasco
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain
| | - J P Vialle
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, 74000 Annecy, France
| | - L Q Wang
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - N H Wang
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - Q L Wang
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - X Wang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - X Q Wang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Z X Wang
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - J Wei
- DPNC, Université de Genève, 1211 Genève 4, Switzerland
| | - Z L Weng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Wu
- Southeast University (SEU), Nanjing 210096, China
| | - R Q Xiong
- Southeast University (SEU), Nanjing 210096, China
| | - W Xu
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - Q Yan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y Yang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - H Yi
- Southeast University (SEU), Nanjing 210096, China
| | - Y J Yu
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - Z Q Yu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - M Zannoni
- INFN Sezione di Milano-Bicocca, 20126 Milano, Italy
- Università di Milano-Bicocca, 20126 Milano, Italy
| | - S Zeissler
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), 76131 Karlsruhe, Germany
| | - C Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - F Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - J H Zhang
- Southeast University (SEU), Nanjing 210096, China
| | - Z Zhang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - F Zhao
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Z M Zheng
- Beihang University (BUAA), Beijing 100191, China
| | - H L Zhuang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - V Zhukov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - A Zichichi
- INFN Sezione di Bologna, 40126 Bologna, Italy
- Università di Bologna, 40126 Bologna, Italy
| | - N Zimmermann
- I. Physics Institute and JARA-FAME, RWTH Aachen University, 52056 Aachen, Germany
| | - P Zuccon
- INFN TIFPA, 38123 Povo, Trento, Italy
- Università di Trento, 38123 Povo, Trento, Italy
| |
Collapse
|
40
|
Li T, Lv H, Yang L, Xie J, Liu C, Xu P, Li W, Wang S, Yang D, Wu T, Yan J, Luo F. Pharmacokinetics and Tissue Distribution of DVDMS-2 in Tumor-bearing Mice. Photochem Photobiol 2019; 96:148-155. [PMID: 31574562 DOI: 10.1111/php.13171] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2019] [Accepted: 09/26/2019] [Indexed: 01/10/2023]
Abstract
DVDMS-2 is a novel candidate for photodynamic therapy of tumors. The purpose of the present study was to assess the distribution and elimination of DVDMS-2 in mice bearing hepatoma 22 tumors. DVDMS-2 (1, 2 and 4 mg kg-1 ) was injected intravenously into the mice, extracted from biological tissues and quantified using a fluorescence assay. The data obtained were processed with WinNonlin pharmacokinetic software. The fluorescence assay established for DVDMS-2 quantification was a rapid, reproducible, sensitive and specific method with good linearity. The pharmacokinetics of DVDMS-2 in tumor-bearing mice conformed to a two-compartment model. DVDMS-2 accumulated in tumor tissue to a greater extent than adjacent tissues (skin, muscle) and sustained a relatively high-level concentration 12 to 24 h following administration, which may be the optimal treatment time point. In conclusion, DVDMS-2 selectively accumulated in tumor tissue and was eliminated at a rapid rate in tumor-bearing mice, suggesting that DVDMS-2 may have few side effects, including skin phototoxicity. The present study established the pharmacokinetic characteristics of DVDMS-2, which may be beneficial in future clinical study.
Collapse
Affiliation(s)
- Tingting Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Haiyan Lv
- Xiamen Mental Health Center, Xiamen Xianyue Hospital, Xiamen, Fujian, China
| | - Liu Yang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Jun Xie
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Cong Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Peilan Xu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Wanyun Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Dong Yang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Ting Wu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian, China
| |
Collapse
|
41
|
Hou M, Bao X, Luo F, Chen X, Liu L, Wu M. HMGA2 Modulates the TGFβ/Smad, TGFβ/ERK and Notch Signaling Pathways in Human Lens Epithelial-Mesenchymal Transition. Curr Mol Med 2019; 18:71-82. [PMID: 29974827 DOI: 10.2174/1566524018666180705104844] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2018] [Revised: 05/24/2018] [Accepted: 07/02/2018] [Indexed: 11/22/2022]
Abstract
BACKGROUND AND OBJECTIVE Multiple signaling pathways coordinately promote epithelial-mesenchymal transition (EMT) in lens epithelial cells (LECs), where transforming growth factor beta (TGFβ)-mediated signaling plays a central role. But the mechanism of crosstalk among these pathways remains obscure. The objective of this study is to investigate the regulatory effect of the high mobility group protein A2 (HMGA2) on the signaling pathways in lens fibrosis. METHODS The human anterior capsulorhexis specimens were collected. The human SRA01/04 LEC line was cultured and treated with recombinant human TGFβ2 (5ng/ml). For inhibition of signaling pathways, a selective inhibitor SB431542, U0126 or DAPT was added to LECs respectively. The specific small interfering RNA (siRNA) were transfected to LECs for gene silence. The mRNAs expressions were measured by realtime PCR and the proteins expressions were determined by western blot and immunofluorescent staining. RESULTS HMGA2 and EMT markers α-smooth muscle actin (SMA), fibronectin (FN) and collagen type I (Col I) were overexpressed in human ASC specimens and TGFβ2 stimulated EMT in LECs. While blockage of EMT by a selective inhibitor of TGFβ/Smad, TGFβ/extracellular signal-regulated kinase (ERK) or Notch signaling pathway could significantly inhibited HMGA2 protein expression. And silence of HMGA2 by siRNA could significantly inhibit TGFβ2 induced expression of EMT markers including FN, Col I, collagen type IV (Col IV), key transcription factors Snail and Slug, and remarkably upregulate the epithelial markers E-cadherin and tight junction protein (ZO-1). In addition, silence of HMGA2 gene could abrogate TGFβ2 induced phosphorylation of Smad2, Smad3 as well as ERK1/2. Blockage of HMGA2 could also inhibit the upregulation of Jagged1, Notch2, and Notch3 induced by TGFβ2. CONCLUSION This study indicated that HMGA2 functions as a shared effector in TGFβ2- induced lens fibrosis, modulating the signaling network necessary for EMT in a positive feedback loop.
Collapse
Affiliation(s)
- M Hou
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
| | - X Bao
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.,Department of Ophthalmology, Ophthalmology & Optometry Center, Peking University People's Hospital, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, Beijing 100044, China
| | - F Luo
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
| | - X Chen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
| | - L Liu
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
| | - M Wu
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China
| |
Collapse
|
42
|
Xu P, Zou M, Wang S, Li T, Liu C, Wang L, Wang L, Luo F, Wu T, Yan J. Construction and characterization of a truncated tissue factor‑coagulation‑based composite system for selective thrombosis in tumor blood vessels. Int J Oncol 2019; 55:823-832. [PMID: 31432158 PMCID: PMC6741845 DOI: 10.3892/ijo.2019.4855] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2019] [Accepted: 07/24/2019] [Indexed: 12/14/2022] Open
Abstract
The selective induction of tumor vascular thrombosis using truncated tissue factor (tTF) delivered via a target ligand is a promising novel antitumor strategy. In the present study, an anti-neuropilin-1 (NRP-1) monoclonal antibody (mAb)-streptavidin (SA):tTF-biotin (B) composite system was established. In this system, anti-NRP-1-mAb located tTF to the tumor vascular endothelial cell surface and induced vascular embolization. Due to their high binding affinity, SA and B were used to enhance thrombogenic activity. mAb was conjugated with SA using a coupling method with water-soluble 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide and N-hydroxysulfosuccinimide. Biotinylated tTF (tTF-B) was prepared using a B-labeling kit subsequent to the generation and purification of fusion protein tTF. Confocal microscopy and flow cytometry indicated that the anti-NRP-1-mAb-SA conjugate retained mAb targeting activity. The preservation of B-conjugate binding capacity was confirmed using a competitive ELISA, and factor X-activation analysis revealed that tTF-B retained the procoagulant activity exhibited by tTF. Live imaging was performed to assess mAb-SA distribution and tumor-targeting capability, and this yielded promising results. The results of in vivo studies in mice with subcutaneous xenografts demonstrated that this composite system significantly induced tumor vascular thrombosis and inhibited tumor growth, whereas these histological changes were not observed in normal organs.
Collapse
Affiliation(s)
- Peilan Xu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Mingyuan Zou
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Shengyu Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Tingting Li
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Cong Liu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Li Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Lanlan Wang
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Fanghong Luo
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Ting Wu
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| | - Jianghua Yan
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, Fujian 361102, P.R. China
| |
Collapse
|
43
|
Thompson MC, Wolff AM, Nango E, Kubo M, Young ID, Nakane T, Sugahara M, Tanaka R, Ito K, Brewster AS, Sierra RG, Yumoto F, Nomura T, Owada S, Hino T, Tosha T, Tanaka T, Im D, Aquila A, Carbajo S, Koralek J, Yamashita A, Luo F, Boutet S, Sauter NK, Tono K, Iwata S, Fraser JS. Turning up the heat on dynamic proteins: observing molecular motion in real time with temperature-jump X-ray crystallography. Acta Crystallogr A Found Adv 2019. [DOI: 10.1107/s0108767319098349] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
44
|
Li R, Luo F. Safety and Efficacy of Aspirin Desensitization Combined With Long-Term Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease. J Investig Allergol Clin Immunol 2019; 30:327-333. [PMID: 31283521 DOI: 10.18176/jiaci.0433] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
OBJECTIVES To assess the safety and efficacy of Aspirin desensitization combined with long-term Aspirin therapy in patients with Aspirinexacerbated respiratory disease (AERD). METHODS We searched the PubMed, Ovid, Cochrane Library, and Google Scholar databases from inception to October 2018 for articles in English. We only included randomized controlled trials and parallel or cross-over studies in which adults with AERD were randomly assigned to undergo Aspirin desensitization and receive long-term Aspirin therapy or placebo. RESULTS A total of 869 citations were retrieved, and 6 studies met the criteria for analysis. All studies indicated that nasal symptoms, asthma symptoms, or both improved significantly after Aspirin desensitization. In addition, most studies reported a decline in corticosteroid dosage (oral and inhaled). The 4 studies that reported nasal polyps did not demonstrate a change in nasal polyps with Aspirin therapy compared with placebo. The dropout rates in all studies reviewed ranged from 5.8% to 55.7%, and the most common adverse events were gastrointestinal symptoms. CONCLUSIONS Clearly, Aspirin desensitization and treatment are beneficial for AERD patients, with relief of nasal symptoms, improvement in asthma control, decrease in daily corticosteroid use, and no fatal adverse events. However, the long-term adverse effects of Aspirin desensitization and optimal dosage of Aspirin merit further investigation.
Collapse
Affiliation(s)
- R Li
- Department of General Medicine, West China Hospital of Sichuan University, Chengdu, China
| | - F Luo
- Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, China
| |
Collapse
|
45
|
Zhang H, Li Y, Pan Z, Chen Y, Fan Z, Tian H, Zhou S, Zhang Y, Shang J, Jiang B, Wang F, Luo F, Hou Z. Multifunctional Nanosystem Based on Graphene Oxide for Synergistic Multistage Tumor-Targeting and Combined Chemo-Photothermal Therapy. Mol Pharm 2019; 16:1982-1998. [PMID: 30892898 DOI: 10.1021/acs.molpharmaceut.8b01335] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Locating nanomedicines at the active sites plays a pivotal role in the nanoparticle-based cancer therapy field. Herein, a multifunctional nanotherapeutic is designed by using graphene oxide (GO) nanosheets with rich carboxyl groups as the supporter for hyaluronic acid (HA)-methotrexate (MTX) prodrug modification via an adipicdihydrazide cross-linker, achieving synergistic multistage tumor-targeting and combined chemo-photothermal therapy. As a tumor-targeting biomaterial, HA can increase affinity of the nanocarrier toward CD44 receptor for enhanced cellular uptake. MTX, a chemotherapeutic agent, can also serve as a tumor-targeting enhancer toward folate receptor based on its similar structure with folic acid. The prepared nanosystems possess a sheet shape with a dynamic size of approximately 200 nm and pH-responsive drug release. Unexpectedly, the physiological stability of HA-MTX prodrug-decorated GO nanosystems in PBS, serum, and even plasma is more excellent than that of HA-decorated GO nanosystems, while both of them exhibit an enhanced photothermal effect than GO nanosheets. More importantly, because of good blood compatibility as well as reduced undesired interactions with blood components, HA-MTX prodrug-decorated GO nanosystems exhibited remarkably superior accumulation at the tumor sites by passive and active targeting mechanisms, achieving highly effective synergistic chemo-photothermal therapeutic effect upon near-infrared laser irradiation, efficient ablation of tumors, and negligible systemic toxicity. Hence, the HA-MTX prodrug-decorated hybrid nanosystems have a promising potential for synergistic multistage tumor-targeting therapy.
Collapse
Affiliation(s)
| | - Yang Li
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, and Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter , Chinese Academy of Sciences , Fuzhou 350002 , China.,Department of Translational Medicine, Xiamen Institute of Rare Earth Materials , Chinese Academy of Sciences , Xiamen 361024 , P. R. China
| | | | | | | | | | - Song Zhou
- Department of General Surgery , The Affiliated Southeast Hospital of Xiamen University , Zhangzhou 363000 , China
| | | | | | | | | | | | | |
Collapse
|
46
|
Aguilar M, Ali Cavasonza L, Alpat B, Ambrosi G, Arruda L, Attig N, Azzarello P, Bachlechner A, Barao F, Barrau A, Barrin L, Bartoloni A, Basara L, Başeğmez-du Pree S, Battiston R, Becker U, Behlmann M, Beischer B, Berdugo J, Bertucci B, Bindi V, de Boer W, Bollweg K, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Cai XD, Capell M, Caroff S, Casaus J, Castellini G, Cervelli F, Chang YH, Chen GM, Chen HS, Chen Y, Cheng L, Chou HY, Choutko V, Chung CH, Clark C, Coignet G, Consolandi C, Contin A, Corti C, Crispoltoni M, Cui Z, Dadzie K, Dai YM, Datta A, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Di Felice V, Dimiccoli F, Díaz C, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Eronen T, Feng J, Fiandrini E, Fisher P, Formato V, Galaktionov Y, García-López RJ, Gargiulo C, Gast H, Gebauer I, Gervasi M, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Guo KH, Haino S, Han KC, He ZH, Heil M, Hsieh TH, Huang H, Huang ZC, Incagli M, Jia Y, Jinchi H, Kanishev K, Khiali B, Kirn T, Konak C, Kounina O, Kounine A, Koutsenko V, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Leluc C, Li JQ, Li Q, Li TX, Li ZH, Light C, Lin CH, Lippert T, Liu FZ, Liu H, Liu Z, Lu SQ, Lu YS, Luebelsmeyer K, Luo F, Luo JZ, Luo X, Lyu SS, Machate F, Mañá C, Marín J, Martin T, Martínez G, Masi N, Maurin D, Menchaca-Rocha A, Meng Q, Mo DC, Molero M, Mott P, Mussolin L, Nelson T, Ni JQ, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Paniccia M, Pashnin A, Pauluzzi M, Pensotti S, Perrina C, Phan HD, Picot-Clemente N, Plyaskin V, Pohl M, Poireau V, Popkow A, Quadrani L, Qi XM, Qin X, Qu ZY, Rancoita PG, Rapin D, Conde AR, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Solano C, Schael S, Schmidt SM, von Dratzig AS, Schwering G, Seo ES, Shan BS, Shi JY, Siedenburg T, Song JW, Sun ZT, Tacconi M, Tang XW, Tang ZC, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Urban T, Vagelli V, Valente E, Valtonen E, Acosta MV, Vecchi M, Velasco M, Vialle JP, Vizán J, Wang LQ, Wang NH, Wang QL, Wang X, Wang XQ, Wang ZX, Wei J, Weng ZL, Wu H, Xiong RQ, Xu W, Yan Q, Yang Y, Yi H, Yu YJ, Yu ZQ, Zannoni M, Zeissler S, Zhang C, Zhang F, Zhang JH, Zhang Z, Zhao F, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zimmermann N, Zuccon P. Towards Understanding the Origin of Cosmic-Ray Electrons. Phys Rev Lett 2019; 122:101101. [PMID: 30932626 DOI: 10.1103/physrevlett.122.101101] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/07/2019] [Indexed: 06/09/2023]
Abstract
Precision results on cosmic-ray electrons are presented in the energy range from 0.5 GeV to 1.4 TeV based on 28.1×10^{6} electrons collected by the Alpha Magnetic Spectrometer on the International Space Station. In the entire energy range the electron and positron spectra have distinctly different magnitudes and energy dependences. The electron flux exhibits a significant excess starting from 42.1_{-5.2}^{+5.4} GeV compared to the lower energy trends, but the nature of this excess is different from the positron flux excess above 25.2±1.8 GeV. Contrary to the positron flux, which has an exponential energy cutoff of 810_{-180}^{+310} GeV, at the 5σ level the electron flux does not have an energy cutoff below 1.9 TeV. In the entire energy range the electron flux is well described by the sum of two power law components. The different behavior of the cosmic-ray electrons and positrons measured by the Alpha Magnetic Spectrometer is clear evidence that most high energy electrons originate from different sources than high energy positrons.
Collapse
Affiliation(s)
- M Aguilar
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - L Ali Cavasonza
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - B Alpat
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - G Ambrosi
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - L Arruda
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), P-1000 Lisboa, Portugal
| | - N Attig
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, D-52425 Jülich, Germany
| | - P Azzarello
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - A Bachlechner
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Barao
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), P-1000 Lisboa, Portugal
| | - A Barrau
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, F-38000 Grenoble, France
| | - L Barrin
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | | | - L Basara
- INFN TIFPA, I-38123 Povo, Trento, Italy
| | - S Başeğmez-du Pree
- KVI-Center for Advanced Radiation Technology, University of Groningen, NL-9700 AB Groningen, Netherlands
| | - R Battiston
- INFN TIFPA, I-38123 Povo, Trento, Italy
- Università di Trento, I-38123 Povo, Trento, Italy
| | - U Becker
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Behlmann
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - B Beischer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - J Berdugo
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - B Bertucci
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - V Bindi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - W de Boer
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - K Bollweg
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - B Borgia
- INFN Sezione di Roma 1, I-00185 Roma, Italy
- Università di Roma La Sapienza, I-00185 Roma, Italy
| | - M J Boschini
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
| | - M Bourquin
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - E F Bueno
- Instituto de Física de São Carlos, Universidade de São Paulo, CP 369, 13560-970, São Carlos, São Paulo, SP, Brazil
| | - J Burger
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | | | - X D Cai
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Capell
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - S Caroff
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - J Casaus
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | | | - F Cervelli
- INFN Sezione di Pisa, I-56100 Pisa, Italy
| | - Y H Chang
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - G M Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - H S Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Y Chen
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - L Cheng
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - H Y Chou
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - V Choutko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C H Chung
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - C Clark
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Coignet
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - C Consolandi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Contin
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - C Corti
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - M Crispoltoni
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - Z Cui
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - K Dadzie
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y M Dai
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - A Datta
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C Delgado
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - S Della Torre
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
| | - M B Demirköz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - L Derome
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, F-38000 Grenoble, France
| | - S Di Falco
- INFN Sezione di Pisa, I-56100 Pisa, Italy
| | - V Di Felice
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - F Dimiccoli
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
- INFN TIFPA, I-38123 Povo, Trento, Italy
| | - C Díaz
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - P von Doetinchem
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Dong
- Southeast University (SEU), Nanjing, 210096, China
| | - F Donnini
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - M Duranti
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - A Egorov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Eline
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - T Eronen
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - J Feng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - E Fiandrini
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - P Fisher
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Formato
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - Y Galaktionov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - R J García-López
- Instituto de Astrofísica de Canarias (IAC), E-38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Spain
| | - C Gargiulo
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | - H Gast
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - I Gebauer
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - M Gervasi
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - F Giovacchini
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - D M Gómez-Coral
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - J Gong
- Southeast University (SEU), Nanjing, 210096, China
| | - C Goy
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - V Grabski
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - D Grandi
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - M Graziani
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - K H Guo
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - S Haino
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - K C Han
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan, 32546, Taiwan
| | - Z H He
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - M Heil
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - T H Hsieh
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Huang
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - Z C Huang
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - M Incagli
- INFN Sezione di Pisa, I-56100 Pisa, Italy
| | - Yi Jia
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Jinchi
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan, 32546, Taiwan
| | | | - B Khiali
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - Th Kirn
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - C Konak
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - O Kounina
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kounine
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Koutsenko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kulemzin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - G La Vacca
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - E Laudi
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | - G Laurenti
- INFN Sezione di Bologna, I-40126 Bologna, Italy
| | - I Lazzizzera
- INFN TIFPA, I-38123 Povo, Trento, Italy
- Università di Trento, I-38123 Povo, Trento, Italy
| | - A Lebedev
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H T Lee
- Academia Sinica Grid Center (ASGC), Nankang, Taipei, 11529, Taiwan
| | - S C Lee
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - C Leluc
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - J Q Li
- Southeast University (SEU), Nanjing, 210096, China
| | - Q Li
- Southeast University (SEU), Nanjing, 210096, China
| | - T X Li
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - Z H Li
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - C Light
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C H Lin
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - T Lippert
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, D-52425 Jülich, Germany
| | - F Z Liu
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Hu Liu
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan, 32054, Taiwan
| | - Z Liu
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - S Q Lu
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - Y S Lu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - K Luebelsmeyer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Luo
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - J Z Luo
- Southeast University (SEU), Nanjing, 210096, China
| | - Xi Luo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - S S Lyu
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - F Machate
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - C Mañá
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - J Marín
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - T Martin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - G Martínez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - N Masi
- INFN Sezione di Bologna, I-40126 Bologna, Italy
| | - D Maurin
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, F-38000 Grenoble, France
| | - A Menchaca-Rocha
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - Q Meng
- Southeast University (SEU), Nanjing, 210096, China
| | - D C Mo
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - M Molero
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - P Mott
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - L Mussolin
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - T Nelson
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - J Q Ni
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - N Nikonov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Nozzoli
- INFN TIFPA, I-38123 Povo, Trento, Italy
| | - A Oliva
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - M Orcinha
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), P-1000 Lisboa, Portugal
| | - M Palermo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Palmonari
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - M Paniccia
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - A Pashnin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Pauluzzi
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - S Pensotti
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - C Perrina
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - H D Phan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | | | - V Plyaskin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Pohl
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - V Poireau
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - A Popkow
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - L Quadrani
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - X M Qi
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - X Qin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Z Y Qu
- Institute of Physics, Academia Sinica, Nankang, Taipei, 11529, Taiwan
| | - P G Rancoita
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
| | - D Rapin
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - A Reina Conde
- Instituto de Astrofísica de Canarias (IAC), E-38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Spain
| | - S Rosier-Lees
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - A Rozhkov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - D Rozza
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - R Sagdeev
- East-West Center for Space Science, University of Maryland, College Park, Maryland 20742, USA
| | - C Solano
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - S Schael
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - S M Schmidt
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, D-52425 Jülich, Germany
| | - A Schulz von Dratzig
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - G Schwering
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - E S Seo
- IPST, University of Maryland, College Park, Maryland 20742, USA
| | - B S Shan
- Beihang University (BUAA), Beijing 100191, China
| | - J Y Shi
- Southeast University (SEU), Nanjing, 210096, China
| | - T Siedenburg
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - J W Song
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Z T Sun
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - M Tacconi
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - X W Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - Z C Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - J Tian
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - Samuel C C Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | - S M Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - N Tomassetti
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - J Torsti
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - T Urban
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- National Aeronautics and Space Administration Johnson Space Center (JSC), Houston, Texas 77058, USA
| | - V Vagelli
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - E Valente
- INFN Sezione di Roma 1, I-00185 Roma, Italy
- Università di Roma La Sapienza, I-00185 Roma, Italy
| | - E Valtonen
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - M Vázquez Acosta
- Instituto de Astrofísica de Canarias (IAC), E-38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Spain
| | - M Vecchi
- KVI-Center for Advanced Radiation Technology, University of Groningen, NL-9700 AB Groningen, Netherlands
- Instituto de Física de São Carlos, Universidade de São Paulo, CP 369, 13560-970, São Carlos, São Paulo, SP, Brazil
| | - M Velasco
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - J P Vialle
- Univ. Grenoble Alpes, Univ. Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - J Vizán
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - L Q Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - N H Wang
- Shandong University (SDU), Jinan, Shandong, 250100, China
| | - Q L Wang
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - X Wang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - X Q Wang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Z X Wang
- Sun Yat-Sen University (SYSU), Guangzhou, 510275, China
| | - J Wei
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - Z L Weng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Wu
- Southeast University (SEU), Nanjing, 210096, China
| | - R Q Xiong
- Southeast University (SEU), Nanjing, 210096, China
| | - W Xu
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Q Yan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y Yang
- National Cheng Kung University, Tainan, 70101, Taiwan
| | - H Yi
- Southeast University (SEU), Nanjing, 210096, China
| | - Y J Yu
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - Z Q Yu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - M Zannoni
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - S Zeissler
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - C Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - F Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - J H Zhang
- Southeast University (SEU), Nanjing, 210096, China
| | - Z Zhang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - F Zhao
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Z M Zheng
- Beihang University (BUAA), Beijing 100191, China
| | - H L Zhuang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - V Zhukov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - A Zichichi
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - N Zimmermann
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - P Zuccon
- INFN TIFPA, I-38123 Povo, Trento, Italy
- Università di Trento, I-38123 Povo, Trento, Italy
| |
Collapse
|
47
|
Tu L, Zeng Z, Wang L, Luo F. [Effect of aspirin on breast cancer stem cells and stemness of breast cancer]. Zhonghua Yi Xue Za Zhi 2019; 98:3598-3602. [PMID: 30486577 DOI: 10.3760/cma.j.issn.0376-2491.2018.44.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Objective: To explore the effect of aspirin on the stemness of breast cancer cells and apoptosis induction of breast cancer stem cells. Methods: The 4T1 cells cultured with stem cell culture medium were screened, and immunofluorescence technique, flow cytometry and tumor-forming experiment in vivo were applied to test stem cell characteristics of the tumor spheres. After dealt with aspirin, the apoptosis rate of 4T1 stem cells was analyzed by flow cytometry. The 4T1 cells were cultured in vitro and treated with aspirin, then flow cytometry analysis was used to detect the expression of aldehydedehy drogenase1 (ALDH1), and the expression of stemness genes was tested by Western blot . Then, after culturing the cells with medium containing basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), B27 and N2, the ability of sphere-forming was observed and recorded by microscopy. In vivo BALB/c mice inoculated with 4T1 stem cells were randomly divided into the control group, 10 mg/kg, 30 mg/kg and 100 mg/kg aspirin groups. After 10 days, the mice were dealt with aspirin or NS for 15 days, then the tumor growth was observed and recorded. Results: The ratio of ALDH1 positive cells was up to 78.55%, and 4T1 tumor sphere had a postive expression of ALDH1 and sex determining region Y-box 2 (SOX2). In vivo tumorigenesis abilities of tumor sphere with 1×10(2) 4T1 stem cells could be 75%, while the ratio of normal cells was zero. The ratio of Aspirin-induced apoptosis of 4T1 stem cells at early stage and and late stage increased from 0.36% to 21.61%, and from 4.21% to 21.38%, respectively. Flow cytometry and Western blot assay results indicated that aspirin could reduce the expression of ALDH1, SOX2, octamer-binding transcription factor 4 (OCT4) and NANOG in 4T1 cells. Sphere-forming experiments results showed that aspirin could inhibit sphere forming ability of breast cancer cells. In vivo, aspirin inhibited the growth of tumors with a dose-dependent manner. Conclusion: Aspirin could induce apoptosis of cancer stem cells and reduce stemness of breast cancer, and thus play a growth-inhibiting action on breast cancer.
Collapse
Affiliation(s)
- L Tu
- Department of Lung Cancer Center, State Key Laboratory, West China Hospital, Sichuan University, Chengdu 610041, China
| | | | | | | |
Collapse
|
48
|
Affiliation(s)
- Z Zeng
- From the Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, and Lung Cancer Center
| | - H Liao
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China
| | - F Luo
- From the Department of Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, and Lung Cancer Center
| | - F Lin
- Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, China
| |
Collapse
|
49
|
Aguilar M, Ali Cavasonza L, Ambrosi G, Arruda L, Attig N, Azzarello P, Bachlechner A, Barao F, Barrau A, Barrin L, Bartoloni A, Basara L, Başeğmez-du Pree S, Battiston R, Becker U, Behlmann M, Beischer B, Berdugo J, Bertucci B, Bindi V, de Boer W, Bollweg K, Borgia B, Boschini MJ, Bourquin M, Bueno EF, Burger J, Burger WJ, Cai XD, Capell M, Caroff S, Casaus J, Castellini G, Cervelli F, Chang YH, Chen GM, Chen HS, Chen Y, Cheng L, Chou HY, Choutko V, Chung CH, Clark C, Coignet G, Consolandi C, Contin A, Corti C, Crispoltoni M, Cui Z, Dadzie K, Dai YM, Datta A, Delgado C, Della Torre S, Demirköz MB, Derome L, Di Falco S, Dimiccoli F, Díaz C, von Doetinchem P, Dong F, Donnini F, Duranti M, Egorov A, Eline A, Eronen T, Feng J, Fiandrini E, Fisher P, Formato V, Galaktionov Y, García-López RJ, Gargiulo C, Gast H, Gebauer I, Gervasi M, Giovacchini F, Gómez-Coral DM, Gong J, Goy C, Grabski V, Grandi D, Graziani M, Guo KH, Haino S, Han KC, He ZH, Heil M, Hsieh TH, Huang H, Huang ZC, Incagli M, Jia Y, Jinchi H, Kanishev K, Khiali B, Kirn T, Konak C, Kounina O, Kounine A, Koutsenko V, Kulemzin A, La Vacca G, Laudi E, Laurenti G, Lazzizzera I, Lebedev A, Lee HT, Lee SC, Leluc C, Li JQ, Li Q, Li TX, Li ZH, Light C, Lin CH, Lippert T, Liu FZ, Liu H, Liu Z, Lu SQ, Lu YS, Luebelsmeyer K, Luo F, Luo JZ, Luo X, Lyu SS, Machate F, Mañá C, Marín J, Martin T, Martínez G, Masi N, Maurin D, Menchaca-Rocha A, Meng Q, Mo DC, Molero M, Mott P, Mussolin L, Nelson T, Ni JQ, Nikonov N, Nozzoli F, Oliva A, Orcinha M, Palermo M, Palmonari F, Paniccia M, Pashnin A, Pauluzzi M, Pensotti S, Perrina C, Phan HD, Picot-Clemente N, Plyaskin V, Pohl M, Poireau V, Popkow A, Quadrani L, Qi XM, Qin X, Qu ZY, Rancoita PG, Rapin D, Conde AR, Rosier-Lees S, Rozhkov A, Rozza D, Sagdeev R, Solano C, Schael S, Schmidt SM, Schulz von Dratzig A, Schwering G, Seo ES, Shan BS, Shi JY, Siedenburg T, Song JW, Sun ZT, Tacconi M, Tang XW, Tang ZC, Tian J, Ting SCC, Ting SM, Tomassetti N, Torsti J, Urban T, Vagelli V, Valente E, Valtonen E, Vázquez Acosta M, Vecchi M, Velasco M, Vialle JP, Vizán J, Wang LQ, Wang NH, Wang QL, Wang X, Wang XQ, Wang ZX, Wei J, Weng ZL, Wu H, Xiong RQ, Xu W, Yan Q, Yang Y, Yi H, Yu YJ, Yu ZQ, Zannoni M, Zeissler S, Zhang C, Zhang F, Zhang JH, Zhang Z, Zhao F, Zheng ZM, Zhuang HL, Zhukov V, Zichichi A, Zimmermann N, Zuccon P. Towards Understanding the Origin of Cosmic-Ray Positrons. Phys Rev Lett 2019; 122:041102. [PMID: 30768313 DOI: 10.1103/physrevlett.122.041102] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/21/2018] [Revised: 12/04/2018] [Indexed: 06/09/2023]
Abstract
Precision measurements of cosmic ray positrons are presented up to 1 TeV based on 1.9 million positrons collected by the Alpha Magnetic Spectrometer on the International Space Station. The positron flux exhibits complex energy dependence. Its distinctive properties are (a) a significant excess starting from 25.2±1.8 GeV compared to the lower-energy, power-law trend, (b) a sharp dropoff above 284_{-64}^{+91} GeV, (c) in the entire energy range the positron flux is well described by the sum of a term associated with the positrons produced in the collision of cosmic rays, which dominates at low energies, and a new source term of positrons, which dominates at high energies, and (d) a finite energy cutoff of the source term of E_{s}=810_{-180}^{+310} GeV is established with a significance of more than 4σ. These experimental data on cosmic ray positrons show that, at high energies, they predominantly originate either from dark matter annihilation or from other astrophysical sources.
Collapse
Affiliation(s)
- M Aguilar
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - L Ali Cavasonza
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - G Ambrosi
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - L Arruda
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), P-1000 Lisboa, Portugal
| | - N Attig
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, D-52425 Jülich, Germany
| | - P Azzarello
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - A Bachlechner
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Barao
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), P-1000 Lisboa, Portugal
| | - A Barrau
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, F-38000 Grenoble, France
| | - L Barrin
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | | | - L Basara
- INFN TIFPA, I-38123 Povo, Trento, Italy
| | - S Başeğmez-du Pree
- KVI-Center for Advanced Radiation Technology, University of Groningen, NL-9700 AB Groningen, the Netherlands
| | - R Battiston
- INFN TIFPA, I-38123 Povo, Trento, Italy
- Università di Trento, I-38123 Povo, Trento, Italy
| | - U Becker
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Behlmann
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - B Beischer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - J Berdugo
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - B Bertucci
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - V Bindi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - W de Boer
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - K Bollweg
- National Aeronautics and Space Administration Johnson Space Center (JSC), Jacobs Engineering, and Business Integra, Houston, Texas 77058, USA
| | - B Borgia
- INFN Sezione di Roma 1, I-00185 Roma, Italy
- Università di Roma La Sapienza, I-00185 Roma, Italy
| | - M J Boschini
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
| | - M Bourquin
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - E F Bueno
- Instituto de Física de São Carlos, Universidade de São Paulo, CP 369, 13560-970 São Carlos, São Paulo, SP, Brazil
| | - J Burger
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | | | - X D Cai
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Capell
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - S Caroff
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - J Casaus
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | | | - F Cervelli
- INFN Sezione di Pisa, I-56100 Pisa, Italy
| | - Y H Chang
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan 32054, Taiwan
| | - G M Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - H S Chen
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Y Chen
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - L Cheng
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - H Y Chou
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan 32054, Taiwan
| | - V Choutko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - C H Chung
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - C Clark
- National Aeronautics and Space Administration Johnson Space Center (JSC), Jacobs Engineering, and Business Integra, Houston, Texas 77058, USA
| | - G Coignet
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - C Consolandi
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - A Contin
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - C Corti
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - M Crispoltoni
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - Z Cui
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - K Dadzie
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y M Dai
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - A Datta
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C Delgado
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - S Della Torre
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
| | - M B Demirköz
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - L Derome
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, F-38000 Grenoble, France
| | - S Di Falco
- INFN Sezione di Pisa, I-56100 Pisa, Italy
| | - F Dimiccoli
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
- INFN TIFPA, I-38123 Povo, Trento, Italy
| | - C Díaz
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - P von Doetinchem
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Dong
- Southeast University (SEU), Nanjing 210096, China
| | - F Donnini
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - M Duranti
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - A Egorov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Eline
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - T Eronen
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - J Feng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - E Fiandrini
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - P Fisher
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Formato
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - Y Galaktionov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - R J García-López
- Instituto de Astrofísica de Canarias (IAC), E-38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Spain
| | - C Gargiulo
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | - H Gast
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - I Gebauer
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - M Gervasi
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - F Giovacchini
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - D M Gómez-Coral
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - J Gong
- Southeast University (SEU), Nanjing 210096, China
| | - C Goy
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - V Grabski
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - D Grandi
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - M Graziani
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - K H Guo
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - S Haino
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - K C Han
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan 32546, Taiwan
| | - Z H He
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - M Heil
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - T H Hsieh
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Huang
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - Z C Huang
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - M Incagli
- INFN Sezione di Pisa, I-56100 Pisa, Italy
| | - Yi Jia
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Jinchi
- National Chung-Shan Institute of Science and Technology (NCSIST), Longtan, Tao Yuan 32546, Taiwan
| | | | - B Khiali
- INFN Sezione di Perugia, I-06100 Perugia, Italy
| | - Th Kirn
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - C Konak
- Department of Physics, Middle East Technical University (METU), 06800 Ankara, Turkey
| | - O Kounina
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kounine
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - V Koutsenko
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - A Kulemzin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - G La Vacca
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - E Laudi
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | - G Laurenti
- INFN Sezione di Bologna, I-40126 Bologna, Italy
| | - I Lazzizzera
- INFN TIFPA, I-38123 Povo, Trento, Italy
- Università di Trento, I-38123 Povo, Trento, Italy
| | - A Lebedev
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H T Lee
- Academia Sinica Grid Center (ASGC), Nankang, Taipei 11529, Taiwan
| | - S C Lee
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - C Leluc
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - J Q Li
- Southeast University (SEU), Nanjing 210096, China
| | - Q Li
- Southeast University (SEU), Nanjing 210096, China
| | - T X Li
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - Z H Li
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - C Light
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - C H Lin
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - T Lippert
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, D-52425 Jülich, Germany
| | - F Z Liu
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Hu Liu
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- Physics Department and Center for High Energy and High Field, National Central University (NCU), Tao Yuan 32054, Taiwan
| | - Z Liu
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - S Q Lu
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - Y S Lu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - K Luebelsmeyer
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Luo
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - J Z Luo
- Southeast University (SEU), Nanjing 210096, China
| | - Xi Luo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - S S Lyu
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - F Machate
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - C Mañá
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - J Marín
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - T Martin
- National Aeronautics and Space Administration Johnson Space Center (JSC), Jacobs Engineering, and Business Integra, Houston, Texas 77058, USA
| | - G Martínez
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - N Masi
- INFN Sezione di Bologna, I-40126 Bologna, Italy
| | - D Maurin
- Univ. Grenoble Alpes, CNRS, Grenoble INP, LPSC-IN2P3, F-38000 Grenoble, France
| | - A Menchaca-Rocha
- Instituto de Física, Universidad Nacional Autónoma de México (UNAM), México, D. F., 01000 Mexico
| | - Q Meng
- Southeast University (SEU), Nanjing 210096, China
| | - D C Mo
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - M Molero
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - P Mott
- National Aeronautics and Space Administration Johnson Space Center (JSC), Jacobs Engineering, and Business Integra, Houston, Texas 77058, USA
| | - L Mussolin
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - T Nelson
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - J Q Ni
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - N Nikonov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - F Nozzoli
- INFN TIFPA, I-38123 Povo, Trento, Italy
| | - A Oliva
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - M Orcinha
- Laboratório de Instrumentação e Física Experimental de Partículas (LIP), P-1000 Lisboa, Portugal
| | - M Palermo
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - F Palmonari
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - M Paniccia
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - A Pashnin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Pauluzzi
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - S Pensotti
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - C Perrina
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - H D Phan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | | | - V Plyaskin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - M Pohl
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - V Poireau
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - A Popkow
- Physics and Astronomy Department, University of Hawaii, Honolulu, Hawaii 96822, USA
| | - L Quadrani
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - X M Qi
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - X Qin
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Z Y Qu
- Institute of Physics, Academia Sinica, Nankang, Taipei 11529, Taiwan
| | - P G Rancoita
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
| | - D Rapin
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - A Reina Conde
- Instituto de Astrofísica de Canarias (IAC), E-38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Spain
| | - S Rosier-Lees
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - A Rozhkov
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - D Rozza
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - R Sagdeev
- East-West Center for Space Science, University of Maryland, College Park, Maryland 20742, USA
| | - C Solano
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - S Schael
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - S M Schmidt
- Jülich Supercomputing Centre and JARA-FAME, Research Centre Jülich, D-52425 Jülich, Germany
| | - A Schulz von Dratzig
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - G Schwering
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - E S Seo
- IPST, University of Maryland, College Park, Maryland 20742, USA
| | - B S Shan
- Beihang University (BUAA), Beijing 100191, China
| | - J Y Shi
- Southeast University (SEU), Nanjing 210096, China
| | - T Siedenburg
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - J W Song
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - Z T Sun
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - M Tacconi
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - X W Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - Z C Tang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - J Tian
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - Samuel C C Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
- European Organization for Nuclear Research (CERN), CH-1211 Geneva 23, Switzerland
| | - S M Ting
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - N Tomassetti
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - J Torsti
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - T Urban
- National Aeronautics and Space Administration Johnson Space Center (JSC), Jacobs Engineering, and Business Integra, Houston, Texas 77058, USA
| | - V Vagelli
- INFN Sezione di Perugia, I-06100 Perugia, Italy
- Università di Perugia, I-06100 Perugia, Italy
| | - E Valente
- INFN Sezione di Roma 1, I-00185 Roma, Italy
- Università di Roma La Sapienza, I-00185 Roma, Italy
| | - E Valtonen
- Space Research Laboratory, Department of Physics and Astronomy, University of Turku, FI-20014 Turku, Finland
| | - M Vázquez Acosta
- Instituto de Astrofísica de Canarias (IAC), E-38205 La Laguna, and Departamento de Astrofísica, Universidad de La Laguna, E-38206 La Laguna, Tenerife, Spain
| | - M Vecchi
- KVI-Center for Advanced Radiation Technology, University of Groningen, NL-9700 AB Groningen, the Netherlands
- Instituto de Física de São Carlos, Universidade de São Paulo, CP 369, 13560-970 São Carlos, São Paulo, SP, Brazil
| | - M Velasco
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - J P Vialle
- Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS, LAPP-IN2P3, F-74000 Annecy, France
| | - J Vizán
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), E-28040 Madrid, Spain
| | - L Q Wang
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - N H Wang
- Shandong University (SDU), Jinan, Shandong 250100, China
| | - Q L Wang
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - X Wang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - X Q Wang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Z X Wang
- Sun Yat-Sen University (SYSU), Guangzhou 510275, China
| | - J Wei
- DPNC, Université de Genève, CH-1211 Genève 4, Switzerland
| | - Z L Weng
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - H Wu
- Southeast University (SEU), Nanjing 210096, China
| | - R Q Xiong
- Southeast University (SEU), Nanjing 210096, China
| | - W Xu
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Q Yan
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - Y Yang
- National Cheng Kung University, Tainan 70101, Taiwan
| | - H Yi
- Southeast University (SEU), Nanjing 210096, China
| | - Y J Yu
- Institute of Electrical Engineering (IEE), Chinese Academy of Sciences, Beijing 100190, China
| | - Z Q Yu
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - M Zannoni
- INFN Sezione di Milano-Bicocca, I-20126 Milano, Italy
- Università di Milano-Bicocca, I-20126 Milano, Italy
| | - S Zeissler
- Institut für Experimentelle Teilchenphysik, Karlsruhe Institute of Technology (KIT), D-76131 Karlsruhe, Germany
| | - C Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - F Zhang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - J H Zhang
- Southeast University (SEU), Nanjing 210096, China
| | - Z Zhang
- Massachusetts Institute of Technology (MIT), Cambridge, Massachusetts 02139, USA
| | - F Zhao
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
- University of Chinese Academy of Sciences (UCAS), Beijing 100049, China
| | - Z M Zheng
- Beihang University (BUAA), Beijing 100191, China
| | - H L Zhuang
- Institute of High Energy Physics (IHEP), Chinese Academy of Sciences, Beijing 100049, China
| | - V Zhukov
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - A Zichichi
- INFN Sezione di Bologna, I-40126 Bologna, Italy
- Università di Bologna, I-40126 Bologna, Italy
| | - N Zimmermann
- I. Physics Institute and JARA-FAME, RWTH Aachen University, D-52056 Aachen, Germany
| | - P Zuccon
- INFN TIFPA, I-38123 Povo, Trento, Italy
- Università di Trento, I-38123 Povo, Trento, Italy
| |
Collapse
|
50
|
Zou M, Samiullah M, Xu P, Wang S, He J, Wu T, Luo F, Yan J. Construction of novel procoagulant protein targeting neuropilin-1 on tumour vasculature for tumour embolization therapy. J Drug Target 2019; 27:885-895. [PMID: 30628471 DOI: 10.1080/1061186x.2019.1566337] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The cellular transmembrane receptor Neuropilin-1(NRP-1) is overexpressed in tumour tissue and endothelial cells of tumour vessels, whereas it has limited expression in normal tissues. This study aimed to design a novel recombinant protein tTF-EG3287, which consisting of the truncated tissue factor (tTF) and the NRP-1 targeting peptide EG3287. The procoagulant protein selectively activates blood coagulation in tumour vessels once bound to the cell surface of the tumour vasculature by a targeting peptide EG3287. In this study, procoagulant activity of the recombinant protein tTF-EG3287 was evaluated by Spectozyme FXa assay. NRP-1 targeting ability was analysed by fluorescence confocal microscopy and flow cytometry. The living imaging system was used to assess the tumour targeting ability of recombinant proteins tTF-EG3287 in vivo. Tumour growth inhibition showed effective antitumor activity in HepG2 tumour-bearing nude mice. Histological study showed obvious thrombosis and thromboembolism in tumour vessels and cell necrosis of tumour tissue, without any clear side effect such as thrombosis in other organs.
Collapse
Affiliation(s)
- Mingyuan Zou
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| | - Malik Samiullah
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| | - Peilan Xu
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| | - Shengyu Wang
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| | - Jie He
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| | - Ting Wu
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| | - Fanghong Luo
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| | - Jianghua Yan
- a Cancer Research Center, Medical College , Xiamen University , Xiamen , China
| |
Collapse
|